Ultrasound ablation catheter with cooling infusion and centering basket

Description

TECHNICAL FIELD

The present disclosure relates generally to systems and methods for nerve modulation techniques such as ablation of nerve tissue or other modulation techniques through the walls of blood vessels.

BACKGROUND

Certain treatments may require the temporary or permanent interruption or modification of selected nerve function. One exemplary treatment is renal nerve ablation, which is sometimes used to treat conditions related to congestive heart failure or hypertension. The kidneys produce a sympathetic response to congestive heart failure, which, among other effects, increases the undesired retention of water and/or sodium. Ablating some of the nerves running to the kidneys may reduce or eliminate this sympathetic function, which may provide a corresponding reduction in the associated undesired symptoms.

Many nerves (and nervous tissue such as brain tissue), including renal nerves, run along the walls of or in close proximity to blood vessels and thus can be accessed intravascularly through the walls of the blood vessels. In some instances, it may be desirable to ablate perivascular nerves using ultrasonic energy. In other instances, the perivascular nerves may be ablated by other means including application of thermal, radiofrequency, laser, microwave, and other related energy sources to the target region. Ultrasound transducers may dissipate some energy as heat into the blood and surrounding tissue as well as causing the ultrasound transducers to become hot. This may result in blood damage, clotting, and/or protein fouling of the transducer among other undesirable side effects. In some instances, overheating of the ultrasound transducer may result in the failure of the transducers.

SUMMARY

The present disclosure is directed to an intravascular nerve modulation system for performing nerve ablation.

Accordingly, one illustrative embodiment includes an intravascular nerve modulation system having a catheter shaft. The catheter shaft may define a first lumen and having a proximal end and a distal end. Further, the system includes a first flexible mount member affixed to the distal end of the catheter shaft and defining one or more through holes. Furthermore, the system includes a cylindrical ablation transducer coupled to the first flexible mount and defining a lumen extending distally from the first flexible mount. Here, the lumen of the catheter shaft, the through holes of the first flexible mount member, and the lumen of the transducer are in fluid communication with one another.

Another illustrative embodiment includes an intravascular nerve modulation system that may include an elongate shaft having a proximal end, a distal end, and a lumen extending therebetween. Further, the system may include an ablation transducer affixed to the elongate shaft adjacent the distal end thereof. Furthermore, the intravascular modulation system may include an expandable basket having a proximal end affixed to the elongate shaft and a distal end affixed to an end cap positioned distal of a distal end of the ablation transducer. Here, the expandable basket may be configured to actuate between a first collapsed configuration and a second expanded configuration. In addition, the expandable basket can include two or more longitudinally extending struts and one or more temperature sensors may be coupled to the expandable basket. The system can further include a pull wire affixed to the end cap such that actuation of the pull wire moves the expandable basket between the first collapsed position and the second expanded position. Alternatively, the expandable basket may be configured to self-expand. The system can further include an infusion sheath secured adjacent to the distal end of the elongate tubular member such that the infusion sheath is configured to extend over the ablation transducer. In some instances, the distal end of the expandable basket may be affixed to the elongate shaft.

Another example intravascular nerve modulation system may include an elongate shaft having a proximal end region and a distal end region. An ablation transducer may be coupled to the distal end region of the shaft. An expandable basket may be coupled to the distal end region of the shaft. The expandable basket may have a proximal end dispsoed proximal of the ablation transducer and a distal end disposed distal of the ablation transducer. The expandable basket may be capable of shifting between a first configuration and an expanded configuration. A sensor may be coupled to the expandable basket.

Another example intravascular nerve modulation system may include an elongate shaft having a proximal end region and a distal end region. An ultrasound transducer may be coupled to the distal end region of the shaft. An expandable basket may be coupled to the distal end region of the shaft. The expandable basket may have a proximal end disposed proximal of the ultrasound transducer and a distal end disposed distal of the ultrasound transducer. The expandable basket may be capable of shifting between a first configuration and an expanded configuration. A sensor may be coupled to the expandable basket. The sensor may be capable of contacting a vessel wall when the basket is in the expanded configuration. The sensor may also be designed to monitor the progress of ablation by the ultrasound transducer during an ablation procedure.

Although discussed with specific reference to use with the renal nerves of a patient, the intravascular nerve modulation systems in accordance with the disclosure may be adapted and configured for use in other parts of the anatomy, such as the nervous system, the circulatory system, or other parts of the anatomy of a patient.

The above summary of an example embodiment is not intended to describe each disclosed embodiment or every implementation of the present disclosure.

BRIEF DESCRIPTION OF THE DRAWINGS

The disclosure may be more completely understood in consideration of the following detailed description of various embodiments in connection with the accompanying drawings, in which:

FIG. 1 illustrates an exemplary renal nerve modulation system in situ.

FIG. 2 illustrates a schematic side-view of a portion of an illustrative intravascular nerve modulation system disposed within a body lumen.

FIG. 3A illustrates a schematic side-view of a portion of another illustrative intravascular nerve modulation system in a collapsed configuration.

FIG. 3B illustrates a schematic side-view of the intravascular nerve modulation system of FIG. 3A in an expanded configuration.

FIG. 4 illustrates a schematic side-view of a portion of another illustrative intravascular nerve modulation system.

FIG. 5 illustrates a schematic side-view of a portion of another example of an intravascular nerve modulation system disposed within a body lumen.

FIG. 6 illustrates a cross-sectional view of a portion of another illustrative intravascular nerve modulation system.

FIG. 7 illustrates a cross-sectional view of the illustrative nerve modulation system of FIG. 6.

While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit aspects of the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.

DETAILED DESCRIPTION

For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.

All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may be indicative as including numbers that are rounded to the nearest significant figure.

The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4 , and 5).

Although some suitable dimensions ranges and/or values pertaining to various components, features and/or specifications are disclosed, one of the skill in the art, incited by the present disclosure, would understand desired dimensions, ranges and/or values may deviate from those expressly disclosed.

As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.

For purposes of this disclosure, “proximal” refers to the end closer to the device operator during use, and “distal” refers to the end further from the device operator during use.

The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The detailed description and the drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the disclosure. The illustrative embodiments depicted are intended only as exemplary. Selected features of any illustrative embodiment may be incorporated into an additional embodiment unless clearly stated to the contrary.

It is noted that references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc., indicate that the embodiment described may include a particular feature, structure, or characteristic, but every embodiment may not necessarily include the particular feature, structure, or characteristic. Moreover, such phrases are not necessarily referring to the same embodiment. Further, when a particular feature, structure, or characteristic is described in connection with one embodiment, it should be understood that such feature, structure, or characteristic may also be used connection with other embodiments whether or not explicitly described unless clearly stated to the contrary.

Certain treatments are aimed at the temporary or permanent interruption or modification of select nerve function. In some instances, the nerves are sympathetic nerves. One example treatment is renal nerve ablation, which is sometimes used to treat conditions related to hypertension, congestive heart failure, diabetes, or other conditions impacted by high blood pressure or salt retention. The kidneys produce a sympathetic response to congestive heart failure, which, among other effects, increases the undesired retention of water and/or sodium. Ablating some of the nerves running to the kidneys may reduce or eliminate this sympathetic function, which may provide a corresponding reduction in the associated undesired symptoms.

Some embodiments of the present disclosure relate to a power generating and control apparatus, often for the treatment of targeted tissue in order to achieve a therapeutic effect. In some embodiments, the target tissue is tissue containing or proximate to nerves. In one embodiment, the target tissue includes renal arteries and associated renal nerves. In other embodiments, the target tissue is sympathetic nerves including, for example, sympathetic nerves disposed adjacent to blood vessels. In still other embodiments the target tissue is luminal tissue, which may further comprise diseased tissue such as that found in arterial disease.

While the systems and methods described herein are discussed relative to renal nerve modulation, it is contemplated that the systems and methods may be used in other locations and/or applications where nerve modulation and/or other tissue modulation including heating, activation, blocking, disrupting, or ablation are desired, such as, but not limited to: blood vessels, urinary vessels, or in other tissues via trocar and cannula access. For example, the devices and methods described herein can be applied to hyperplastic tissue ablation, tumor ablation, benign prostatic hyperplasia therapy, nerve excitation or blocking or ablation, modulation of muscle activity, hyperthermia or other warming of tissues, etc. In some instances, it may be desirable to ablate perivascular renal nerves with ultrasound ablation. The term modulation refers to ablation and other techniques that may alter the function of affected nerves.

Ultrasound energy may be used to generate heat at a target location. The high frequency acoustic waves produced by an ultrasonic transducer may be directed at a target region and absorbed at the target region. As the energy emitted is absorbed, a temperature of the target region may rise. In order to perform renal nerve ablation, target nerves should be heated sufficiently to make them nonfunctional, while thermal injury to the artery wall is undesirable. Heating of the artery wall during the procedure may increase pain, which is also undesirable. When a portion of tissue is ablated, tissue properties change, and increased attenuation of the ultrasound energy can make ablation past this ablated tissue difficult. Ultrasound ablation catheters may also generate significant heat in the ultrasound transducer. That heat may consequently form blood clots on or around the transducer, damage the surrounding blood, and/or damaging the transducers, among other undesirable side effects. As the ablation transducer(s) heat, the energy conversion efficiency of those devices is lowered, thus generating even more heat. Thus, normal operations of ablation transducers may be characterized by increasingly lower efficiency during operation. The efficiency of the ablation transducers may be enhanced using a cooling mechanism. One possible cooling mechanism is passing an infusion fluid over the transducers.

FIG. 1 is a schematic view of an illustrative nerve modulation system 100 in situ. The nerve modulation system 100 may include an element 102 for providing power to a transducer disposed adjacent to, about, and/or within a central elongated shaft 104 and, optionally, within a guide catheter 106. A proximal end of the element 102 may be connected to a power and control element 108, which supplies the necessary electrical energy to activate the one or more transducers at or near a distal end of the element 102. The power and control element 108 may include monitoring elements to monitor parameters such as power, temperature, voltage, pulse size and/or frequency and other suitable parameters as well as suitable controls for performing the desired procedure. In some instances, the control unit 108 may control an ultrasound ablation transducer. The ablation transducer may be configured to operate at a frequency of about 9-10 megahertz (MHz). It is contemplated that any desired frequency may be used, for example, from 1-20 MHz. In addition, it is contemplated that frequencies outside this range may also be used, as desired. While the term “ultrasound” is used herein, this is not meant to limit the range of vibration frequencies contemplated. For example, it is contemplated that the perivascular nerves may be ablated by other means including application of thermal, radiofrequency, laser, microwave, and other related energy sources to the target region.

FIG. 2 illustrates a schematic side view of a distal end portion of an illustrative intravascular nerve modulation system 200 disposed within a body lumen 204 having a vessel wall 202. Local body tissue (not shown) may surround the vessel wall 202. The local body tissue may comprise adventitia and connective tissues, nerves, fat, fluid, etc., in addition to the muscular vessel wall 202. A portion of the surrounding tissue may constitute the desired treatment region. For instance, one or more renal nerves (not shown) may extend along the outer wall of the body lumen 204.

The system 200 may include an elongate catheter shaft 208 having a proximal end (not shown) and a distal end region 211. The elongate shaft 208 may extend proximally from the distal end region 211 to the proximal end configured to remain outside of a patient's body. Although not shown, the proximal end of the elongate shaft 208 may include a hub attached thereto for connecting other treatment devices or providing a port for facilitating other treatments. It is contemplated that the stiffness of the elongate shaft 208 may be modified to form the modulation system 200 for use in various vessel diameters and various locations within the vascular tree.

In some instances, the elongate shaft 208 may have an elongate tubular structure and may include one or more lumens extending therethrough. For instance, in the illustrated embodiment, the elongate shaft 208 includes a lumen 209 having a guidewire wire 220 slidably disposed therein, however, this is not required. In some embodiments, the elongate shaft may include one or more auxiliary lumens. In some instances, the elongate shaft 208 may include a separate lumen(s) (not shown) for infusion of fluids or for other purposes such as the introduction of a medical device, and so forth. The fluid may facilitate cooling of the modulation system 200 during the ablation procedure, in addition to the cooling of body lumen 204. Further, the lumens may be configured in any way known in the art. For example, the lumen may extend along the entire length of the elongate shaft 208 such as in an over-the-wire catheter or may extend only along a distal portion of the elongate shaft 208 such as in a single operator exchange (SOE) catheter. These examples are not intended to be limiting, but rather examples of some possible configurations. While not explicitly shown, the modulation system 200 may further include temperature sensors/wire, an infusion lumen, radiopaque marker bands, fixed guidewire tip, a guidewire lumen, and/or other components to facilitate the use and advancement of the system 200 within the vasculature.

Further, the elongate shaft 208 may have a relatively long, thin, flexible tubular configuration. In some instances, the elongate shaft 208 may have a generally circular cross-section, however, other suitable configurations such as, but not limited to, rectangular, oval, irregular, or the like may also be contemplated. In addition, the elongate shaft 208 may have a cross-sectional configuration adapted to be received in a desired vessel, such as a renal artery. For instance, the elongate shaft 208 may be sized and configured to accommodate passage through the intravascular path, which leads from a percutaneous access site in, for example, the femoral, brachial, or radial artery, to a targeted treatment site, for example, within a renal artery.

Materials employed to manufacture the elongate shaft 208 may include any suitable biocompatible material. Examples may include metals, polymers, alloys, shape memory materials, etc. Other suitable materials known in the art may also be employed.

The system 200 may further include one or more ablation transducers 210 positioned adjacent the distal end region 211 of the elongate shaft 208. While FIG. 2 illustrates a single ablation transducer 210, it is contemplated that the modulation system 200 may include any number of ablation transducers desired, such as, but not limited to, one, two, three, or more. The ablation transducer 210 is configured to deliver acoustic energy (i.e., ultrasound waves) to the target region around the vessel wall 202. In some instances, the frequency of the ultrasound energy used for the procedure may be set so that the ablated area of tissue starts after it passes through the vessel wall 202 thereby minimizing potential heat damage of the vessel wall 202. While the ablation transducer 210 is described as an ultrasonic transducer, it is contemplated that other methods and devices for raising the temperature of the nerves may be used, such as, but not limited to: radiofrequency, microwave, other acoustic, optical, electrical current, direct contact heating, or other heating.

In some embodiments, the ablation transducer 210 may have a cylindrical shape, however, those skilled in the art will appreciate that any suitable shapes such as, but not limited to, square, rectangular, polygonal, circular, oblong, or the like may also be contemplated. In some instances, such as when a cylindrical transducer is provided, the ablation transducer 210 may extend around the entire circumference of the elongate shaft 208. In an alternative embodiment, however, the ablation transducer 210 may extend partially around the circumference of the elongate shaft 208. For instance, the ablation transducer 210 may include an array of one or more transducers (not shown) positioned about the circumference of the elongate shaft 208. In other embodiments, the ablation transducer 210 may comprise a focused or phased array of transducers. The array may be configured to be directed at a focus region such that multiple transducers are radiating energy at a common target region. It is further contemplated that the ablation transducer 210 may comprise a plurality of longitudinally spaced transducers. Those skilled in the art will appreciate that other suitable configurations of the ablation transducer 210 may also be contemplated without departing from the scope and spirit of the present disclosure.

The ablation transducer 210 may be formed from any suitable material such as, but not limited to, lead zirconate titanate (PZT). It is contemplated that other ceramic or piezoelectric materials may also be used. In some instances, the ablation transducer 210 may include a layer of gold, or other conductive layer, disposed on the acoustically functional areas of the transducer 210 surface for connecting electrical leads to the ablation transducer 210. It is contemplated that the sides/edges of the transducer crystal may be free of conductive material so as not to “short circuit” the transducer 210. In some instances, one or more tie layers may be used to bond the gold to the PZT. For example, a layer of chrome may be disposed between the PZT and the gold to improve adhesion. In other instances, the transducer 210 may include a layer of chrome over the PZT followed by a layer of nickel, and finally a layer of gold. These are just examples. It is contemplated that the layers may be deposited on the PZT using sputter coating, although other deposition techniques may be used as desired.

The ablation transducer 210 may have a radiating surface, and a perimeter surface extending around the outer edge of the ablation transducer 210. The acoustic energy from the radiating surface of the ablation transducer 210 may be transmitted in a spatial pressure distribution related to the shape of the ablation transducer 210. For instance, the cylindrical shape of the ablation transducer 210 may provide a circumferential ablation pattern. In such an instance, the ablation transducer 210 may include a backing layer to direct the acoustic energy in a single direction. In other embodiments, the ablation transducer 210 may be structured to radiate acoustic energy from two radiating surfaces.

In some embodiments, an electrical conductor, such as the element 102 (as shown in FIG. 1), may connect the ablation transducer 210 to a power and control unit (such as control unit 108 in FIG. 1). In some embodiments, the electrical conductor(s) may be disposed within a lumen of the elongate shaft 208. In other embodiments, the electrical conductor(s) may extend along an outside surface of the elongate shaft 208. The electrical conductor(s) may provide electricity to the ablation transducer 210, which may then be converted into acoustic energy. The acoustic energy may be directed from the ablation transducer 210 in a direction generally perpendicular to the radiating surfaces of the transducer 210. As discussed above, acoustic energy radiates from the ablation transducer 210 in a pattern related to the shape of the transducer 210 and lesions formed during ablation take shape similar to contours of the pressure distribution.

The system 200 can further include an expandable frame or basket 212 having a proximal end 213 and a distal end 215. The proximal end 213 of the expandable basket 212 may be affixed to the elongate shaft 208 proximal to the ablation transducer 210 and the distal end 215 may be affixed to elongate shaft 208 distal to the ablation transducer 210. However, it is contemplated that the expandable basket 212 may be positioned along any portion of the elongate shaft 208 desired. The proximal and distal ends 213, 215 of the basket 212 may be affixed to the elongate shaft 208 in any manner desired. For example, in some instances, a band or retaining element 218 may be used to secure the proximal and distal ends 213, 215. In other instances, the proximal and distal ends 213, 215 may be secured to the elongate shaft 208 with an adhesive or other suitable method. It is further contemplated that either or both of the proximal or distal ends 213, 215 may be secured to an element other than the elongate shaft 208 to facilitate expansion and/or contraction of the basket 212.

The expandable basket 212 may include one or more generally longitudinally extending struts 214a 214b , 214c , 214d , 214e , and 214f (collectively referred to hereinafter as struts 214). Although six struts 214 are shown in FIG. 2, it should be noted that any suitable number of struts 214 may be employed for desired purposes. Further, the expandable basket 212 may be configured to actuate between a first collapsed configuration and a second expanded configuration (shown in FIG. 2), which may include transition of the struts 214 from a generally straight configuration to a curved configuration, respectively. More particularly, the struts 214 in the collapsed configuration may extend and/or straighten to be generally parallel with or generally extend along the longitudinal length of the elongate shaft 208. In contrast, in the second expanded configuration, as shown in FIG. 2, the struts 214 may expand and/or curve like the ribs of an umbrella to surround the ablation transducer 210.

According to embodiments of the present disclosure, the expandable basket 212 may be adapted to align and position the ablation transducer 210 within the body lumen 204. In particular, the ultrasound transducer 210 may be positioned at the center of the expandable basket 212 in the expanded configuration. The centering of the ablation transducer 210 may result in better blood flow and accurate ablation geometry. To accomplish this, the expandable basket 212 may expand to meet the vessel wall 202, as discussed above. As shown in FIG. 2, the expandable basket 212 in the second expanded configuration may be arranged and positioned to surround the ablation transducer 210 circumferentially. In such an instance, the expandable basket 212 may facilitate circumferential ablation of the target region while allowing continued blood flow along the lumen 204. Therefore, the expandable basket 212 allows blood flow for cooling and for renal perfusion, unlike occlusive balloon approaches. In some other embodiments, although not shown, the expandable basket 212 may include one or more electrodes or transducers disposed along the struts 214 such as to contact the vessel wall 202, capable of creating one or more lesions during the ablation procedure.

The expandable basket 212 may be self-expandable, or may require external force to expand. A self-expandable basket 212 may be formed of any material or structure that is in a compressed state when force is applied and in an expanded state when force is released. Such material may include, for example, shape memory materials such as Nitinol or any other self-expandable material commonly known in the art. When employing such shape-memory materials, the expandable basket 212 may be heat set in the expanded state and then compressed to fit within a delivery sheath such as a guide sheath 222, for example. Upon reaching the target location within the body lumen 204, the guide sheath 222 can be retracted to deploy the expandable basket 212 in the expanded configuration. In another embodiment, a spring may be provided to effect expansion. Alternatively, external forces such as, but not limited to, pneumatic methods, compressed fluid, or the like may also be employed to expand the expandable basket 212.

In addition, the system 200 may include an actuation mechanism, for example, a pull wire, which may be employed to manipulate or actuate the expandable basket 212 between the collapsed and expanded configurations discussed above. In an embodiment, the pull wire may be attached to the proximal end 213 or distal end 215 of the basket 212 such that a push-pull mechanism of the pull wire may manipulate the expandable basket 212, thus actuating the expandable basket 212 between the collapsed and expanded configurations. To this end, the pull wire may be pulled proximally to pull the expandable basket 212, switching the expandable basket 212 to the expanded configurations. In addition, the pull wire may be pushed distally to switch the expandable basket 212 in the collapsed configuration. Alternatively, the pull wire may be pushed distally, which may allow the expandable basket 212 to move to the expanded state. In such instance, the pull wire may be pulled proximally, which may allow the expandable basket 212 to move to the collapsed state.

The system 200 can further include one or more temperature sensors 216a and 216b (collectively referred hereinafter as sensors 216) coupled to the expandable basket 212. Although two temperature sensors 216 are shown, it should be noted that any suitable number of temperature sensors 216 may employed for desired purposes. In addition, other suitable sensors such as impedance sensors may also be employed. As shown, the temperature sensors 216 may be placed on the struts 214 such as to contact the vessel wall 202 in the expanded configuration. The contact between the sensors 216 and the wall 202 may allow measuring of temperature of the vessel wall 202 during the ablation procedure. According to an example, the temperature sensors 216 may include one or more thermocouples, which may be employed to monitor wall 202 temperatures.

As discussed previously, the system 200 may include one or more guide sheaths 222 having a proximal end (not shown), a distal end 221, and a lumen extending therebetween. It should be noted that guide sheath 222 may include any suitable number of lumens as required or desired. The elongate shaft 208 may be slidably disposed within the lumen of the guide sheath 222. In some instances, the guide sheath 222 may also be used as an infusion sheath. For example, the distal end 221 of the guide sheath 222 may be open to allow an infusion fluid to exit. Saline or other suitable infusion fluid (not shown) may be flushed through the lumen 223. In an alternate embodiment, the infusion fluid may exit through the distal end region 211 of the elongate shaft 208, thereby displacing blood from and around the transducer 210. As the infusion fluid flows past the ablation transducer 210, the infusion fluid may provide convective cooling to the ablation transducer 210. It is further contemplated that by displacing and/or cooling the blood surrounding the transducer 210, blood damage, fouling of the transducer 210, and/or overheating of the transducer 210 may be reduced or eliminated. In some instances, this may allow the modulation system 200 to be operated at a higher power level, thus providing a shorter treatment and/or more effective modulation of the target tissue. In some embodiments, the modulation system may be structured to direct some or all of the infusion fluid along the inside of the vessel wall 202. While blood flowing through the vessel lumen 204 removed some heat from the wall tissue, the addition of a “cooling” flush via infusion fluid directed towards the vessel wall 202 may allow the application of more power for a shorter time period. It is contemplated that the infusion fluid may be introduced into the modulation system 200 before, during, or after ablation. Flow of the infusion fluid may begin before energy is supplied to the ablation transducer 210 and continue for the duration of the modulation procedure. In some instances, a separate infusion sheath (not explicitly shown) may be provided, as will be discussed in more detail below.

The infusion fluid may be saline or any other suitable infusion fluid. It is contemplated that the infusion fluid may be provided at a variety of different temperatures depending on the desired treatment. In some instances, the infusion fluid may be provided at room temperature, below room temperature, above room temperature, or at normal body temperature as desired. In addition, the salinity of the infusion fluid can be chosen to obtain desired electrical conductivity, such as to improve the discrimination capability of impedance monitoring. In some instances, such as when an imaging transducer is provided (not explicitly shown), a small amount of an imaging contrast material may be added to the infusion fluid to facilitate imaging of the vessel. Suitable examples of such imaging contrast material may include, but are not limited to fluorine, iodine, barium, or the like.

The modulation system 200 may be advanced through the vasculature in any manner known in the art. For example, system 200 may include a guidewire lumen to allow the system 200 to be advanced over a previously located guidewire, such as guidewire 220. In some embodiments, the modulation system 200 may be advanced, or partially advanced, within a delivery catheter such as the guide catheter 222. Once the transducer 210 of the modulation system 200 has been placed adjacent to the desired treatment area, positioning mechanisms, such as basket 212, may be deployed, if so provided. The transducer 210 may be connected to a power and control unit (such as control unit 108 in FIG. 1) by an electrical conductor. The transducer 210 may be connected to one or more control units, which may provide and/or monitor the system 200 with one or more parameters such as, but not limited to, frequency for performing the desired ablation procedure as well as imaging. In some embodiments, the electrical conductor may be disposed within a lumen of the elongate shaft 208. In other embodiments, the electrical conductor may be extended along an outside surface of the elongate shaft 208.

Once the modulation system 200 has been advanced to the treatment region, the expandable basket 212 may be moved to the expanded configuration to position and align the transducer 210 within the lumen 204. Further, an infusion fluid may be provided through a lumen of an infusion sheath. It is contemplated that energy may be supplied to the ablation transducer 210 before, during, and/or after the expandable basket 212 is shifted to the expanded configuration. The electrical conductor may provide electricity to the ablation transducer 210, and that energy may then be converted into acoustic energy. The acoustic energy may be directed from the ablation transducer 210 in a direction generally perpendicular to the radiating surfaces of the ablation transducer 210, generally in a pattern related to the shape of the ablation transducer 210. Although FIG. 1 illustrates a single electrical conductor 102, it is contemplated that the modulation system 200 may include any number of electrical conductors desired, such as, but not limited to, two, three, or more. For example, if multiple ablation transducers are provided, multiple electrical conductors may be required. The amount of energy delivered to the transducer 210 may be determined by the desired treatment as well as the feedback provided by monitoring devices, such as sensors 216.

In some instances, such as when a transducer does not extend around the entire circumference of the elongate shaft 208, the elongate shaft 208 may be rotated and additional ablation can be performed at multiple locations around the circumference of the lumen 204. In some instances, a slow automated “rotisserie” rotation can be used to work around the circumference of the lumen 204, or a faster spinning can be used to simultaneously ablate around the entire circumference. The spinning can be accomplished with a distal micro-motor or by spinning a drive shaft from the proximal end. In other instances, the elongate shaft 208 may be indexed incrementally between desired orientations. In some embodiments, temperature sensors 216 can provide information that can be used to selectively turn on and off the ablation transducer 210 to warm any cool spots or accommodate for veins, or other tissue variations. The number of times the elongate shaft 208 is rotated at a given longitudinal location may be determined by the number, size and/or shape of the transducer 210 on the elongate shaft 208. Once a particular location has been ablated, it may be desirable to perform further ablation procedures at different longitudinal locations. Once the elongate shaft 208 has been longitudinally repositioned, energy may once again be delivered to the transducer 210 to perform ablation and/or imaging as desired. If necessary, the elongate shaft 208 may be rotated to perform ablation around the circumference of the lumen 204 at each longitudinal location. This process may be repeated at any number of longitudinal locations desired. It is contemplated that in some embodiments, the system 200 may include multiple transducers 210 located at various positions along the length of the elongate shaft 208 such that a larger region may be treated without longitudinal displacement of the elongate shaft 208.

Referring now to FIGS. 3A and 3B, side views of a distal portion of another illustrative intravascular nerve modulation system 300 is depicted. The system 300 may include an elongate shaft 308 having a proximal end region (not shown), a distal end region 311, and a lumen 309 extending therebetween. The elongate shaft 308 may have similar form and function to the elongate shaft 208 discussed above.

The elongate shaft 308 may extend proximally from the distal end region 311 to the proximal end configured to remain outside of a patient's body. Although not shown, the proximal end of the elongate shaft 308 may include a hub attached thereto for connecting other treatment devices or providing a port for facilitating other treatments. It is contemplated that the stiffness of the elongate shaft 308 may be modified to form the modulation system 300 for use in various vessel diameters and various locations within the vascular tree.

The elongate shaft 308 may include one or more lumens extending therethrough. For instance, in the illustrated embodiment, the elongate shaft 308 may include a lumen 309 having a pull wire 320 slidably disposed therein. In some instances, the elongate shaft 308 may include a separate guidewire lumen and/or separate lumen(s) (not shown) for infusion of fluids or for other purposes such as introduction of a medical device, and so forth. The fluid may facilitate cooling of the modulation system 300 during the ablation procedure. Further, the lumen 309 may be configured in any way known in the art. For example, the lumen 309 may extend along the entire length of the elongate shaft 308 such as in an over-the-wire catheter or may extend only along a distal portion of the elongate shaft 308 such as in a single operator exchange (SOE) catheter. These examples are not intended to be limiting, but rather examples of some possible configurations.

Further, the elongate shaft 308 has a relatively long, thin, flexible tubular configuration. In some instances, the elongate shaft 308 may have a generally circular cross-section, however, other suitable configurations such as, but not limited to, rectangular, oval, irregular, or the like may also be contemplated. In addition, the elongate shaft 308 may have a cross-sectional configuration adapted to be received in a desired vessel, such as a renal artery. For instance, the elongate shaft 308 may be sized and configured to accommodate passage through the intravascular path, which leads from a percutaneous access site in, for example, the femoral, brachial, or radial artery, to a targeted treatment site, for example, within a renal artery.

Materials employed to manufacture the elongate shaft 308 may include any suitable biocompatible material. Examples may include metals, polymers, alloys, shape memory alloys, etc. Other suitable materials known in the art may also be employed.

The system 300 may further include one or more ablation transducers 310 positioned adjacent the distal end region 311 of the elongate shaft 308. While FIGS. 3A and 3B illustrate a single ablation transducer 310, it is contemplated that the modulation system 300 may include any number of ablation transducers desired, such as, but not limited to, one, two, three, or more. The ablation transducer 310 is configured to deliver acoustic energy (i.e., ultrasound waves) to the target region around a vessel wall. At the targeted tissue, the acoustic energy is converted to heat, resulting in protein denaturation and coagulative necrosis of the tissue and/or nerves at the target region. In some instances, the frequency of the ultrasound energy used for the procedure may be set so that the ablated area of tissue starts after it passes through the vessel wall thereby minimizing potential heat damage of the vessel wall. The ablation transducer 310 may be similar in form and function to ablation transducer 210 discussed above.

While the ablation transducer 310 is described as an ultrasonic transducer, it is contemplated that other methods and devices for raising the temperature of the nerves may be used, such as, but not limited to: radiofrequency, microwave, other acoustic, optical, electrical current, direct contact heating, or other heating.

Further, the ablation transducer 310 may have a cylindrical shape, however, those skilled in the art will appreciate that any suitable shapes such as, but not limited to, square, rectangular, polygonal, circular, oblong, or the like may also be contemplated. In some instances, such as when a cylindrical transducer is provided, the ablation transducer 310 may extend around the entire circumference of the elongate tubular member 308. In an alternative embodiment, however, the ablation transducer 310 may extend partially around the circumference of the elongate tubular member 208. For instance, the ablation transducer 310 may include an array of one or more transducers (not shown) positioned about the circumference of the elongate tubular member 308. In other embodiments, the ablation transducer 310 may comprise a focused or phased array of transducers. The array may be configured to be directed at a focus region such that multiple transducers are radiating energy at a common target region. It is further contemplated that the ablation transducer 310 may comprise a plurality of longitudinally spaced transducers. Those skilled in the art will appreciate that other suitable configurations of the ablation transducer 310 may also be contemplated without departing from the scope and spirit of the present disclosure.

The ablation transducer 310 may be formed from any suitable material such as, but not limited to, lead zirconate titanate (PZT). It is contemplated that other ceramic or piezoelectric materials may also be used. In some instances, the ablation transducer 310 may include a layer of gold, or other conductive layer, disposed on the acoustically functional areas of the transducer 310 surface for connecting electrical leads to the ablation transducer 310. It is contemplated that the sides/edges of the transducer crystal may be free of conductive material so as not to “short circuit” the transducer 310. In some instances, one or more tie layers may be used to bond the gold to the PZT. For example, a layer of chrome may be disposed between the PZT and the gold to improve adhesion. In other instances, the transducer 310 may include a layer of chrome over the PZT followed by a layer of nickel, and finally a layer of gold. These are just examples. It is contemplated that the layers may be deposited on the PZT using sputter coating, although other deposition techniques may be used as desired.

Although not shown, the ablation transducer 310 may have a radiating surface, and a perimeter surface extending around the outer edge of the ablation transducer 310. The acoustic energy from the radiating surface of the ablation transducer 310 may be transmitted in a spatial pressure distribution related to the shape of the ablation transducer 310. For instance, the cylindrical shape of the ablation transducer 310 may provide a circumferential ablation pattern. In such an instance, the ablation transducer 310 may include a backing layer to direct the acoustic energy in a single direction. In other embodiments, the ablation transducer 310 may be structured to radiate acoustic energy from two radiating surfaces.

In some embodiments, an electrical conductor such as the element 102 (as shown in FIG. 1) may connect the ablation transducer 310 to a control unit (such as control unit 108 in FIG. 1). In some embodiments, the electrical conductor(s) may be disposed within a lumen of the elongated shaft 308. In other embodiments, the electrical conductor(s) may extend along an outside surface of the elongated shaft 308. The electrical conductor(s) 102 may provide electricity to the ablation transducer 310, which may then be converted into acoustic energy. The acoustic energy may be directed from the ablation transducer 310 in a direction generally perpendicular to the radiating surfaces of the transducer 310. As discussed above, acoustic energy radiates from the ablation transducer 310 in a pattern related to the shape of the transducer 310 and lesions formed during ablation take shape similar to contours of the pressure distribution.

The system 300 can further include an expandable basket 312 having a proximal end 313 and a distal end 315. The proximal end 313 may be affixed adjacent the distal end region 311 of the elongate shaft 308 and the distal end 315 may be affixed to an end cap 318 positioned distal of a distal end of the ablation transducer 310. The end cap 318 may have a rounded distal portion 302, which may avoid any injury to the body tissue while the system 300 is introduced in a body lumen.

The expandable basket 312 may include two (or more) generally longitudinally extending struts 314a and 314b (collectively referred hereinafter as struts 314). Although two struts 314 are visible in FIGS. 3A and 3B, it should be noted that any suitable number of struts 314 may be employed for desired purposes. Further, the expandable basket 312 is configured to actuate between a first collapsed configuration and a second expanded configuration, which may include transition of the struts 314 from a generally straight or slightly bowed configuration (as shown in FIG. 3A) to a curved configuration (as shown in FIG. 3B), respectively. More particularly, the struts 314 in the collapsed configuration may extend and/or straighten to be generally parallel with or generally extend along the longitudinal length of the elongate shaft 308, as shown in FIG. 3A. In contrast, in the second expanded configuration, as shown in FIG. 3B, the struts 314 may expand and/or curve like the ribs of an umbrella to surround the ablation transducer 310. Further, the expandable basket 312 may have similar form and function to the expandable basket 212 discussed above.

According to embodiments of the present disclosure, the expandable basket 312 can be adapted to align and position the ablation transducer 310 within a body lumen. To accomplish this, the expandable basket 312 may expand to meet the vessel wall. As shown in FIG. 3B, the expandable basket 312 may expand to the second expanded configuration, which may be arranged and positioned to contact the vessel wall and may position the ablation transducer 310 approximately in the center of the lumen. In such an instance, the expandable basket 312 may facilitate circumferential ablation of the target region while allowing continued blood flow along the lumen. In some other embodiments, although not shown, the expandable basket 312 may include one or more electrodes or transducers disposed along the struts 314 capable of creating lesion(s) while being in contact with the vessel wall.

In the present embodiment, the expandable basket 312 may include an actuation mechanism for moving the basket 312 between the collapsed and expanded positions. For example, the pull wire 320 may be employed to manipulate or actuate the expandable basket 312 between the collapsed and expanded configurations. In an embodiment, the pull wire 320 may be distally attached to the end cap 318 such that a push-pull mechanism of the pull wire 320 may manipulate the expandable basket 312, thus actuating the expandable basket 312 between the collapsed and expanded configurations, respectively. To this end, the pull wire 320, while being affixed to the end cap 318, may be pulled proximally to pull the expandable basket 312, switching the expandable basket 312 to the expanded configurations, as shown in FIG. 3B. In other embodiments, the pull wire 320 may be affixed to the distal end 315 of the basket 312. In this instance, distal actuation of the pull wire 320 may expand the basket 312.

While not explicitly shown, the system 300 may include one or more temperature sensors coupled to the expandable basket 312. In addition, other suitable sensors such as impedance sensors may also be employed. Contact between the sensors and the lumen wall may allow measuring of temperature of the lumen wall during the ablation procedure. According to an example, the temperature sensors may include one or more thermocouples, which may be employed to monitor wall temperatures.

While not explicitly shown, the system 300 can also include one or more guide sheaths having a proximal end, a distal end, and a lumen extending therebetween. The guide sheath may have similar form and function to the guide sheath 222 as discussed above. The elongate shaft 308 may be slidably disposed within the lumen of the guide sheath. In some instances, the guide sheath may also be used as an infusion sheath. For example, the distal end of the guide sheath may be open to allow an infusion fluid to exit. Saline or other suitable infusion fluid (not shown) may be flushed through the lumen.

In an alternate embodiment, an infusion fluid may exit through the distal end region 311 of the elongate shaft 308, thereby displacing blood from and around the transducer 310. As the infusion fluid flows past the ablation transducer 310, the infusion fluid may provide convective cooling to the ablation transducer 310. It is further contemplated that by displacing and/or cooling the blood surrounding the transducer 310, blood damage, fouling of the transducer 310, and/or overheating of the transducer 310 may be reduced or eliminated. In some instances, this may allow the modulation system 300 to be operated at a higher power level, thus providing a shorter treatment and/or more effective modulation of the target tissue. In some embodiments, the modulation system 300 may be structured to direct some or all of the infusion fluid along the inside of the vessel wall. While blood flowing through the vessel lumen removed some heat from the wall tissue, the addition of a “cooling” flush via infusion fluid directed towards the vessel wall may allow the application of more power for a shorter time period. It is contemplated that the infusion fluid may be introduced into the modulation system 300 before, during, or after ablation. Flow of the infusion fluid may begin before energy is supplied to the ablation transducer 310 and continue for the duration of the modulation procedure. In some instances, a separate infusion sheath (not explicitly shown) may be provided, as will be discussed in more detail below.

Although not shown, the modulation system 300 may further include radiopaque marker bands, fixed guidewire tip, a guidewire lumen, and/or other components to facilitate the use and advancement of the system 300 within the vasculature. In addition, the system 300 can further include one or more sensors (e.g. temperature, impedance, etc.) for monitoring the ablation procedure. It should be noted that any suitable number of temperature sensors may employed for desired purposes. In addition, other suitable sensors such as impedance sensors may also be employed.

Turning now to FIG. 4, a side view of a distal portion of another illustrative intravascular nerve modulation system 400 is depicted. The system 400 may include an elongate shaft 408 having a proximal end (not shown), a distal end region 411, and a lumen 409 extending therebetween. The elongate shaft 408 may extend proximally from the distal end region 411 to the proximal end configured to remain outside of a patient's body. Although not shown, the proximal end of the elongate shaft 408 may include a hub attached thereto for connecting other treatment devices or providing a port for facilitating other treatments. It is contemplated that the stiffness of the elongate shaft 408 may be modified to form the modulation system 400 for use in various vessel diameters and various locations within the vascular tree. The elongate shaft 408 may be similar in form and function to elongate shafts 208, 308 discussed above.

The elongate shaft 408 may include one or more lumens extending therethrough. For instance, in the illustrated embodiment, the elongate shaft 408 may include a lumen 409 for receiving a guidewire therethrough. In some instances, the elongate shaft 408 may include a separate guidewire lumen and/or separate lumen(s) (not shown) for infusion of fluids or for other purposes such as introduction of a medical device, and so forth. The fluid may facilitate cooling of the modulation system 400 during the ablation procedure. Further, the lumen 409 may be configured in any way known in the art. For example, the lumen 409 may extend along the entire length of the elongate shaft 408 such as in an over-the-wire catheter or may extend only along a distal portion of the elongate shaft 408 such as in a single operator exchange (SOE) catheter. These examples are not intended to be limiting, but rather examples of some possible configurations. Further, the elongate shaft 408 has a relatively long, thin, flexible tubular configuration. In some instances, the elongate shaft 408 may have a generally circular cross-section, however, other suitable configurations such as, but not limited to, rectangular, oval, irregular, or the like may also be contemplated. In addition, the elongate shaft 408 may have a cross-sectional configuration adapted to be received in a desired vessel, such as a renal artery. For instance, the elongate shaft 408 may be sized and configured to accommodate passage through the intravascular path, which leads from a percutaneous access site in, for example, the femoral, brachial, or radial artery, to a targeted treatment site, for example, within a renal artery.

Materials employed to manufacture the elongate shaft 408 may include any suitable biocompatible material. Examples may include metals, polymers, alloys, shape memory alloys, etc. Other suitable materials known in the art may also be employed.

The system 400 can further include one or more ablation transducers 410 positioned adjacent the distal end region 411 of the elongate shaft 408. While FIG. 4 illustrates single ablation transducer 410, it is contemplated that the modulation system 400 may include any number of ablation transducers desired, such as, but not limited to, one, two, three, or more. The ablation transducer 410 is configured to deliver acoustic energy (i.e., ultrasound waves) to the target region around the vessel wall. At the targeted tissue, the acoustic energy is converted to heat resulting in protein denaturation and coagulative necrosis of the tissue and/or nerves at the target region. In some instances, the frequency of the ultrasound energy used for the procedure may be set so that the ablated area of tissue starts after it passes through the vessel wall thereby minimizing potential heat damage of the vessel wall. The ablation transducer 410 may be similar in form and function to ablation transducers 210, 310 discussed above.

While the ablation transducer 410 is described as an ultrasonic transducer, it is contemplated that other methods and devices for raising the temperature of the nerves may be used, such as, but not limited to: radiofrequency, microwave, other acoustic, optical, electrical current, direct contact heating, or other heating.

Further, the ablation transducer 410 may have a cylindrical shape, however, those skilled in the art will appreciate that any suitable shapes such as, but not limited to, square, rectangular, polygonal, circular, oblong, or the like may also be contemplated. In some instances, such as when a cylindrical transducer is provided, the ablation transducer 410 may extend around the entire circumference of the elongate tubular member 408. In an alternative embodiment, however, the ablation transducer 410 may extend partially around the circumference of the elongate tubular member 408. For instance, the ablation transducer 410 may include an array of one or more transducers (not shown) positioned about the circumference of the elongate tubular member 408. In other embodiments, the ablation transducer 410 may comprise a focused or phased array of transducers. The array may be configured to be directed at a focus region such that multiple transducers are radiating energy at a common target region. It is further contemplated that the ablation transducer 410 may comprise a plurality of longitudinally spaced transducers. Those skilled in the art will appreciate that other suitable configurations of the ablation transducer 410 may also be contemplated without departing from the scope and spirit of the present disclosure.

The ablation transducer 410 may be formed from any suitable material such as, but not limited to, lead zirconate titanate (PZT). It is contemplated that other ceramic or piezoelectric materials may also be used. In some instances, the ablation transducer 410 may include a layer of gold, or other conductive layer, disposed on the acoustically functional areas of the transducer 410 surface for connecting electrical leads to the ablation transducer 410. It is contemplated that the sides/edges of the transducer crystal may be free of conductive material so as not to “short circuit” the transducer 410. In some instances, one or more tie layers may be used to bond the gold to the PZT. For example, a layer of chrome may be disposed between the PZT and the gold to improve adhesion. In other instances, the transducer 210 may include a layer of chrome over the PZT followed by a layer of nickel, and finally a layer of gold. These are just examples. It is contemplated that the layers may be deposited on the PZT using sputter coating, although other deposition techniques may be used as desired.

Although not shown, the ablation transducer 410 may have a radiating surface, and a perimeter surface extending around the outer edge of the ablation transducer 410. The acoustic energy from the radiating surface of the ablation transducer 410 may be transmitted in a spatial pressure distribution related to the shape of the ablation transducer 410. For instance, the cylindrical shape of the ablation transducer 410 may provide a circumferential ablation pattern. In such an instance, the ablation transducer 410 may include a backing layer to direct the acoustic energy in a single direction. In other embodiments, the ablation transducer 410 may be structured to radiate acoustic energy from two radiating surfaces.

In some embodiments, an electrical conductor such as the element 102 (as shown in FIG. 1) may connect the ablation transducer 410 to a control unit (such as control unit 108 in FIG. 1). In some embodiments, the electrical conductor(s) may be disposed within a lumen of the elongated shaft 408. In other embodiments, the electrical conductor(s) may extend along an outside surface of the elongated shaft 408. The electrical conductor(s) may provide electricity to the ablation transducer 410, which may then be converted into acoustic energy. The acoustic energy may be directed from the ablation transducer 410 in a direction generally perpendicular to the radiating surfaces of the transducer 410. As discussed above, acoustic energy radiates from the ablation transducer 410 in a pattern related to the shape of the transducer 410 and lesions formed during ablation take shape similar to contours of the pressure distribution.

The system 400 can further include an expandable basket 412 having a proximal end 413 and a distal end 415. The proximal end 413 of the expandable basket 412 may be affixed adjacent the distal end region 411 of the elongate shaft 408 and the distal end 415 may be affixed to an end cap 418 positioned distal of a distal end of the ablation transducer 410. The end cap 418 may have a rounded distal portion 402, which may avoid any injury to the body tissue while the system 400 is introduced in a body lumen.

The expandable basket 412 may include two (or more) generally longitudinally extending struts 414a and 414b (collectively referred hereinafter as struts 414). Although two struts 414 are visible in FIG. 4, it should be noted that any suitable number of struts 414 may be employed for desired purposes. Further, the expandable basket 412 is configured to actuate between a first collapsed configuration and a second expanded configuration, which may include transition of the struts 414 from a generally straight or slightly bowed configuration to a curved configuration (shown in FIG. 4), respectively. More particularly, the struts 414 in the collapsed configuration may extend and/or straighten generally parallel (not explicitly shown) along the longitudinal length of the elongate shaft 408 similar to struts 314 shown in FIG. 3A. In contrast, in the second expanded configuration (shown in FIG. 4), the struts 414 may expand and/or curve like the ribs of an umbrella to surround the ablation transducer 410. Further, the expandable basket 412 may have similar form and function to the expandable baskets 212, 312 discussed above.

According to embodiments of the present disclosure, the expandable basket 412 can be adapted to align and position the ablation transducer 410 within a body lumen. To accomplish this, the expandable basket 412 may expand to meet the vessel wall. As shown in FIG. 4, the expandable basket 412 may expand to the second expanded configuration, which may be arranged and positioned to contact the vessel wall and may position the ablation transducer 410 approximately in the center of the lumen. In such an instance, the expandable basket 412 may facilitate circumferential ablation of the target region while allowing continued blood flow along the lumen. In some other embodiments, although not shown, the expandable basket 412 may include one or more electrodes or transducers disposed along the struts 414 capable of creating lesion(s) while being in contact with the vessel wall, or to monitor temperature or other characteristics.

In present embodiment, the expandable basket 412 may be self-expandable and may not require external force to expand. Self-expandable expandable basket 412 may be formed of any material or structure that is in a compressed state when force is applied and in an expanded state when force is released. Such material may include, for example, shape memory alloys such as Nitinol or any other self-expandable material commonly known in the art. When employing such shape-memory materials, the expandable basket 412 may be heat set in the expanded state and then compressed to fit within a delivery sheath such as a guide sheath 422, for example. Upon reaching the target location within the body lumen, the infusion sheath 422 can be retracted proximally to deploy the expandable basket 412 in the expanded configuration. In some embodiment, a spring may be provided to effect expansion. Alternatively, external forces such as, but not limited to, pneumatic methods, compressed fluid, or the like may also be employed to expand the expandable basket 412.

Although not shown, the system 400 may include one or more temperature or other suitable sensors coupled to the expandable basket 412. Other suitable sensors may include impedance sensors or other sensors for monitoring the ablation procedure. According to an example, the sensors may be placed on the struts 414 such as to contact the vessel wall in the expanded configuration. The contact between the sensors and the wall may allow for measuring of temperature or other expected physiological parameter of the vessel wall during the ablation procedure. For example, the temperature sensor may include one or more thermocouple, which may be employed to monitor wall temperatures.

In some embodiments, ultrasound imaging may be used to monitor the ablation procedure. It is contemplated that ultrasound imaging may be used to monitor changes deeper in the tissue and adjust the therapy parameter as needed during the ablation procedure. In some instances, this may allow for the identification of nearby vessels that could be removing heat from the targeted tissue around it, thereby allowing increased power delivery, and thus increased heating, to be concentrated in the targeted location.

As discussed above, the system 400 may include a guide sheath 422 having a proximal end (not shown), a distal end 421, and a lumen 423 extending therebetween. The guide sheath may have similar form and function to the guide sheath 222 as discussed above. The elongate shaft 408 may be slidably disposed within the lumen 423 of the guide sheath 422. In some instances, the guide sheath 422 may also be used as an infusion sheath. For example, the distal end 421 of the guide sheath 422 may be open to allow an infusion fluid to exit. Saline or other suitable infusion fluid (not shown) may be flushed through the lumen.

In an alternate embodiment, an infusion fluid may exit through the distal end region 411 of the elongate shaft 408, thereby displacing blood from and around the transducer 410. As the infusion fluid flows past the ablation transducer 410, the infusion fluid may provide convective cooling to the ablation transducer 410. It is further contemplated that by displacing and/or cooling the blood surrounding the transducer 410, blood damage, fouling of the transducer 410, and/or overheating of the transducer 410 may be reduced or eliminated. In some instances, this may allow the modulation system 400 to be operated at a higher power level, thus providing a shorter treatment and/or more effective modulation of the target tissue. In some embodiments, the modulation system 400 may be structured to direct some or all of the infusion fluid along the inside of the vessel wall. While blood flowing through the vessel lumen removed some heat from the wall tissue, the addition of a “cooling” flush via infusion fluid directed towards the vessel wall may allow the application of more power for a shorter time period. It is contemplated that the infusion fluid may be introduced into the modulation system 400 before, during, or after ablation. Flow of the infusion fluid may begin before energy is supplied to the ablation transducer 410 and continue for the duration of the modulation procedure. In some instances, a separate infusion sheath (not explicitly shown) may be provided, as will be discussed in more detail below.

While not explicitly shown, the modulation system 400 may further include radiopaque marker bands, guidewire, a guidewire lumen, and/or other components to facilitate the use and advancement of the system 400 within the vasculature.

FIG. 5 illustrates a side view of a distal portion of another example of an intravascular nerve modulation system 500. The system 500 is disposed within a body lumen 504 having a vessel wall 502 surrounded by local body tissue (not shown). The local body tissue may comprise adventitia and connective tissues, nerves, fat, fluid, etc., in addition to the muscular vessel wall 502. A portion of the surrounding tissue may constitute the desired treatment region. For instance, one or more renal nerves (not shown) may extend substantially longitudinally along the outer wall of the body lumen 504.

The system 500 may include an elongate shaft 508 having a distal end region 511. The elongate shaft 508 may extend proximally from the distal end region 511 to a proximal end configured to remain outside of a patient's body. The proximal end of the elongate shaft 508 may include a hub attached thereto for connecting other treatment devices or providing a port for facilitating other treatments. It is contemplated that the stiffness of the elongate shaft 508 may be modified to form a modulation system 500 for use in various vessel diameters and various locations within the vascular tree. The elongate shaft 508 may further include one or more lumens extending therethrough. For example, the elongate shaft 508 may include a guidewire lumen and/or one or more auxiliary lumens. In some instances, the elongate shaft 508 may include an infusion lumen, as will be discussed in more detail below. The lumens may be configured in any way known in the art. For example, the guidewire lumen may extend the entire length of the elongate shaft 508 such as in an over-the-wire catheter or may extend only along a distal portion of the elongate shaft 508 such as in a single operator exchange (SOE) catheter. These examples are not intended to be limiting, but rather examples of some possible configurations. While not explicitly shown, the modulation system 500 may further include temperature sensors/wire, an infusion lumen, radiopaque marker bands, fixed guidewire tip, a guidewire lumen, external sheath, centering basket, and/or other components to facilitate the use and advancement of the system 500 within the vasculature.

In some embodiments, the elongated catheter shaft 508 may have a relatively long, thin, flexible tubular configuration. In some instances, the elongated shaft 508 may have a generally circular cross-section, however, other suitable configurations such as, but not limited to, rectangular, oval, irregular, or the like may also be contemplated. In addition, the elongated shaft 508 may have a cross-sectional configuration adapted to be received in a desired vessel, such as a renal artery. For instance, the elongated shaft 508 may be sized and configured to accommodate passage through the intravascular path, which leads from a percutaneous access site in, for example, the femoral, brachial, or radial artery, to a targeted treatment site, for example, within a renal artery. Materials employed to manufacture the elongate shaft 508 may include any suitable biocompatible material. Examples may include metals, polymers, alloys, shape memory alloys, etc. Other suitable materials known in the art may also be employed.

The elongated shaft 508 may include a first tubular member 522 and a second tubular member 524. The first tubular member 522 may have a proximal end (not shown), a distal end 521 and a lumen 528 extending between the proximal end and the distal end. In some embodiments, the lumen 528 may be an infusion lumen and may be in fluid communication with an infusion fluid source configured to remain outside of a patient's body. The second tubular member 524 may have a proximal end (not shown), a distal end 530, and a lumen 509 extending therebetween. In some embodiments, the lumen 509 of the second tubular member may be a guidewire lumen for receiving a guidewire 520 therein. The distal end region 532 of the second tubular member 524 extends distally beyond the distal end 521 of the first tubular member 522. In some embodiments, the second tubular member 524 may be disposed within or partially within the lumen 528 of first tubular member 522. In some instances, the second tubular member 524 may be coaxially disposed within the first tubular member 522. In other instances, the longitudinal axis of the second tubular member 524 may be offset from the first tubular member 522. In some instances, the first tubular member 522 and the second tubular member 524 may be advanced through the vasculature together.

In addition, the system 500 may include one or more ablation transducers 510 positioned adjacent to the distal end region 532 of the second tubular member 524. While the ablation transducer 510 is shown and described as being positioned on the second tubular member 524, it is contemplated that in some instances, ablation transducers may be provided on the first tubular member 522. While FIG. 5 illustrates one ablation transducer 510, it is contemplated that the modulation system 500 may include any number of ablation transducers desired, such as, but not limited to, one, two, three, or more.

The ablation transducer 510 is configured to deliver acoustic energy (i.e., ultrasound waves) to the target region around the vessel wall 502. At the targeted tissue, the acoustic energy is converted to heat resulting in protein denaturation and coagulative necrosis of the tissue and/or nerves at the target region. In some instances, the frequency of the ultrasound energy used for the procedure may be set so that the ablated area of tissue starts after it passes through the vessel wall 502 thereby minimizing potential heat damage of the vessel wall 502.

While the ablation transducer 510 is described as an ultrasonic transducer, it is contemplated that other methods and devices for raising the temperature of the nerves may be used, such as, but not limited to: radiofrequency, microwave, other acoustic, optical, electrical current, direct contact heating, or other heating.

Further, the ablation transducer 510 may have a cylindrical shape, however, those skilled in the art will appreciate that any suitable shapes such as, but not limited to, square, rectangular, polygonal, circular, oblong, or the like may also be contemplated. In some instances, such as when a cylindrical transducer is provided, the ablation transducer 510 may extend around the entire circumference of the elongate shaft 508. In an alternative embodiment, however, the ablation transducer 510 may extend partially around the circumference of the elongate shaft 508. For instance, the ablation transducer 510 may include an array of one or more transducers (not shown) positioned about the circumference of the elongate shaft 508. In other embodiments, the ablation transducer 510 may comprise a focused or phased array of transducers. The array may be configured to be directed at a focus region such that multiple transducers are radiating energy at a common target region. It is further contemplated that the ablation transducer 510 may comprise a plurality of longitudinally spaced transducers. Those skilled in the art will appreciate that other suitable configurations of the ablation transducer 510 may also be contemplated without departing from the scope and spirit of the present disclosure.

The ablation transducer 510 may be formed from any suitable material such as, but not limited to, lead zirconate titanate (PZT). It is contemplated that other ceramic or piezoelectric materials may also be used. In some instances, the ablation transducer 510 may include a layer of gold, or other conductive layer, disposed on the acoustically functional areas of the transducer 510 surface for connecting electrical leads to the ablation transducer 510. It is contemplated that the sides/edges of the transducer crystal may be free of conductive material so as not to “short circuit” the transducer 510. In some instances, one or more tie layers may be used to bond the gold to the PZT. For example, a layer of chrome may be disposed between the PZT and the gold to improve adhesion. In other instances, the transducer 510 may include a layer of chrome over the PZT followed by a layer of nickel, and finally a layer of gold. These are just examples. It is contemplated that the layers may be deposited on the PZT using sputter coating, although other deposition techniques may be used as desired.

Although not shown, the ablation transducer 510 may have a radiating surface, and a perimeter surface extending around the outer edge of the ablation transducer 510. The acoustic energy from the radiating surface of the ablation transducer 510 may be transmitted in a spatial pressure distribution related to the shape of the ablation transducer 510. For instance, the cylindrical shape of the ablation transducer 510 may provide a circumferential ablation pattern. In such an instance, the ablation transducer 510 may include a backing layer to direct the acoustic energy in a single direction. In other embodiments, the ablation transducer 510 may be structured to radiate acoustic energy from two radiating surfaces.

In some embodiments, an electrical conductor such as the element 102 (as shown in FIG. 1) may connect the ablation transducer 510 to a control unit (such as control unit 108 in FIG. 1). In some embodiments, the electrical conductor(s) may be disposed within a lumen of the elongated shaft 508. In other embodiments, the electrical conductor(s) may extend along an outside surface of the elongated shaft 508. The electrical conductor(s) may provide electricity to the ablation transducer 510, which may then be converted into acoustic energy. The acoustic energy may be directed from the ablation transducer 510 in a direction generally perpendicular to the radiating surfaces of the transducer 510. As discussed above, acoustic energy radiates from the ablation transducer 510 in a pattern related to the shape of the transducer 510 and lesions formed during ablation take shape similar to contours of the pressure distribution.

The system 500 can further include an expandable frame or basket 512 having a proximal end 513 and a distal end 515. The proximal end 513 of the basket 512 may be affixed to the elongate shaft 508 proximal to the transducer 510. In some instances, the proximal end 513 of the basket 512 may be secured to the first tubular member 522, although this is not required. The distal end 515 of the basket 512 may be affixed to the elongate shaft 508 distal to the transducer 510. In some instances, the distal end 515 of the basket 512 may be secured to the second tubular member 524, although this is not required. The proximal and distal ends 513, 515 of the basket 512 may be affixed to the elongate shaft 508 in any manner desired. For example, in some instances, a band or retaining element may be used to secure the proximal and distal ends 513, 515. In other instances, the proximal and distal ends 513, 515 may be secured to the elongate shaft 508 with an adhesive or other suitable method. It is further contemplated that either or both of the proximal or distal ends 513, 515 may be secured to an element other than the elongate shaft 508 to facilitate expansion and/or contraction of the basket 512.

The expandable basket 512 may include one or more longitudinally extending struts 514a , 514b , 514c , 514d , 514e , and 514f (collectively referred to hereinafter as struts 514). Although six struts 514 are shown in FIG. 5, it should be noted that any suitable number of struts 514 may be employed for desired purposes. Further, the expandable basket 512 may be configured to actuate between a first collapsed configuration and a second expanded configuration (shown in FIG. 5), which may include transition of the struts 514 from a generally straight configuration to a curved configuration, respectively. More particularly, the struts 514 in the collapsed configuration may extend and/or straighten to be generally parallel with or generally extend along the longitudinal length of the elongate shaft 508. In contrast, in the second expanded configuration, the struts 514 may expand and/or curve like the ribs of an umbrella to surround the ablation transducer 510.

According to embodiments of the present disclosure, the expandable basket 512 is adapted to align and position the ablation transducer 510 within the body lumen 504. To accomplish this, the expandable basket 512 may expand to meet the vessel wall 502, as discussed above. As shown in FIG. 5, the expandable basket 512 in the second expanded configuration may be arranged and positioned to generally surround the ablation transducer 510 circumferentially to approximately center the ablation transducer 510 within the lumen 504. In such an instance, the expandable basket 512 may facilitate circumferential ablation of the target region while allowing continued blood flow along the lumen 504. In some other embodiments, although not shown, the expandable basket 512 may include one or more electrodes, sensors, or transducers disposed along the struts 514 such as to contact the vessel wall 502, thereby monitoring a particular characteristic or creating one or more lesions during the ablation procedure.

The expandable basket 512 may be self-expandable, or may require external force to expand. A self-expandable expandable basket 512 may be formed of any material or structure that is in a compressed state when force is applied and in an expanded state when force is released. Such material may include, for example, shape memory alloys such as Nitinol or any other self-expandable material commonly known in the art. When employing such shape-memory materials, the expandable basket 512 may be heat set in the expanded state and then compressed to fit within a delivery sheath such as a guide sheath (not explicitly shown), for example. Upon reaching the target location within the body lumen 504, the guide sheath can be retracted to deploy the expandable basket 512 in the expanded configuration. The guide sheath may have similar form and function to the guide sheath 222 as shown in FIG. 2.

In addition, the system 500 may include an actuation mechanism, for example, a pull wire, which may be employed to manipulate or actuate the expandable basket 512 between the collapsed and expanded configurations discussed above. Although not shown, an actuation element such as a wire may be attached to the proximal end 513 or distal end 515 of the expandable basket 512 such that a push-pull mechanism of the wire may manipulate the expandable basket 512, thus actuating the expandable basket 512 between the collapsed and expanded configurations, respectively. In some instances, the wire may be pulled proximally to compress the length of expandable basket 512, switching the expandable basket 512 to the expanded configurations. In addition, the wire may be pushed distally to elongate the expandable basket 512 into the collapsed configuration. Alternatively, the wire may be pushed distally, compress the length of the expandable basket 512 thus expanding the struts 514 into the expanded state. In such an instance, the wire may be pulled proximally, which may allow the expandable basket 512 to elongate the basket 512 into the collapsed state.

The system can further include one or more temperature sensors 516a and 516b (collectively referred to hereinafter as sensors 516) coupled to the expandable basket 512. Although two temperature sensors 516 are shown, it should be noted that any suitable number of temperature sensors 516 may employed for desired purposes. In addition, other suitable sensors, such as impedance sensors, may also be employed. As shown, the temperature sensors 516 may be placed on the struts 514 such as to contact the vessel wall 502 in the expanded configuration. The contact between the sensors 516 and the wall 502 may allow measuring of temperature of the vessel wall 502 during the ablation procedure. According to an example, the temperature sensors 516 may include one or more thermocouple, which may be employed to monitor wall 502 temperatures.

Further, the system 500 may include one or more infusion sheaths 518 having a proximal end 534, a distal end 536 and a lumen 538 extending therethrough. In some embodiments, the proximal end 534 of the infusion sheath 518 may be secured to the catheter shaft 508 adjacent to the distal end 521 of the first tubular member 522. It is contemplated that the infusion sheath 518 may be attached either temporarily or permanently to the catheter shaft 508. Suitable attachment means may include adhesives, heat shrinking, or other suitable means known to those skilled in the art. The distal end 536 of the infusion sheath 518 may be open to allow an infusion fluid 506 to exit the sheath 518. The infusion sheath 518 may be configured to extend distally from the distal end 521 of the first tubular member 522 such that a portion of the distal end region 532 of the second tubular member 524 is disposed within or partially within the lumen 538 of the infusion sheath 518. In some instances, the distal end 530 of the second tubular member 524 may extend beyond the distal end 536 of the infusion sheath 518, but this is not required. In some instances, the ablation transducer 510 may be disposed within or partially within the lumen 538 of the infusion sheath 518, although this is not required. In some instances, the lumen 538 of the infusion sheath may be in fluid communication with the lumen 528 of the first tubular member 522 for receiving an infusion fluid. Saline or other suitable infusion fluid 506 may be flushed through the infusion lumen 528 and into the lumen 538 of the infusion sheath 518. The infusion fluid 506 may displace blood from around the transducer 510. As the infusion fluid 506 flows past the ablation transducer 510, the infusion fluid 506 may provide convective cooling to the transducer 510. It is further contemplated that by displacing and/or cooling the blood surrounding the transducer 510, blood damage, fouling of the transducer 510, and/or overheating of the transducer 510 may be reduced or eliminated. In some instances, this may allow the modulation system 500 to be operated at a higher power level, thus providing a shorter treatment and/or more effective modulation of the target tissue. In some embodiments, the infusion sheath 518 may be structured to direct some or all of the infusion fluid 506 along the inside of the vessel wall 502. While blood flowing through the vessel lumen 504 removed some heat from the wall tissue, the addition of a “cooling” flush via infusion fluid 506 directed towards the vessel wall 502 may allow the application of more power for a shorter time period. It is contemplated that the infusion fluid 506 may be introduced into the modulation system 500 before, during, or after ablation. Flow of the infusion fluid 506 may begin before energy is supplied to the ablation transducer 510 and continue for the duration of the modulation procedure.

It is contemplated that the infusion sheath 518 may be formed from a material that is sonically translucent such that the ultrasound energy may pass through the infusion sheath 518. In some instances, the infusion sheath may be formed from a polymeric material having a low loss proper acoustic impedance. It is contemplated that the infusion sheath 518 may have a thickness such that significant attenuation of the ultrasound energy is avoided.

The infusion fluid 506 may be saline or any other suitable infusion fluid. It is contemplated that the infusion fluid 506 may be provided at a variety of different temperatures depending on the desired treatment. In some instances, the infusion fluid 506 may be provided at room temperature, below room temperature, above room temperature, or at normal body temperature as desired. In some instances, such as when an imaging transducer is provided (not explicitly shown), a small amount of an imaging contrast material may be added to the infusion fluid 506 to facilitate imaging of the vessel. Suitable examples of such imaging contrast material may include, but are not limited to fluorine, iodine, barium, or the like.

In some embodiments, the infusion sheath 518 may be configured to transition between an expanded state and a collapsed state. It is contemplated that the infusion sheath 518 may be self-expanding or may be expanded using an actuation mechanism

Turning now to FIG. 6, a cross-section of a distal portion of another illustrative intravascular nerve modulation system 600 is depicted. The system 600 may include a hollow cylindrical ablation transducer 610, which may allow for cooling fluid 614 to pass through the lumen 609 of the transducer 610. The system 600 may further include an elongate catheter shaft 602 a support mandrel 612, and flexible mount members 606 and 616.

The catheter shaft 602 may include a first lumen 605, which may extend between a proximal end (not shown) and a distal end 603. The catheter shaft 602 is configured to be introduced within a body lumen (for example, body lumen 204 of FIG. 2). Although not shown, the proximal end of catheter shaft 602 may include a hub attached thereto for connecting other treatment devices or providing a port for facilitating other treatments. It is contemplated that the stiffness of the catheter shaft 602 may be modified to form the modulation system 600 for use in various vessel diameters and various locations within the vascular tree.

In the illustrated embodiment, the first lumen 605 may be configured to slidably receive a guidewire 620 therein. In some embodiments, a guide sheath similar to guide sheaths discussed above (not explicitly shown) may be used in addition to or in place of guidewire 620 to facilitate advancement of the system 600. In addition, the first lumen 605 may be employed for infusion of a fluid 614. Alternatively, the catheter shaft 602 may include separate lumen(s) (not shown) for infusion of fluid 614 or for other purposes such as introduction of a medical device, and so forth. The fluid 614 may facilitate cooling of the modulation system 600 and/or vessel wall during the ablation procedure. Further, the first lumen 605 may be configured in any way known in the art. For example, the first lumen 605 may extend along the entire length of the catheter shaft 602 such as in an over-the-wire catheter or may extend only along a distal portion of the catheter shaft 602 such as in a single operator exchange (SOE) catheter. These examples are not intended to be limiting, but rather examples of some possible configurations.

Further, the catheter shaft 602 may have a relatively long, thin, flexible tubular configuration. In some instances, the catheter shaft 602 may have a generally circular cross-section, however, other suitable configurations such as, but not limited to, rectangular, oval, irregular, or the like may also be contemplated. In addition, the catheter shaft 602 may have a cross-sectional configuration adapted to be received in a desired vessel, such as a renal artery. For instance, the catheter shaft 602 may be sized and configured to accommodate passage through the intravascular path, which leads from a percutaneous access site in, for example, the femoral, brachial, or radial artery, to a targeted treatment site, for example, within a renal artery.

Materials employed to manufacture the catheter shaft 602 may include any suitable biocompatible material. Examples may include metals, polymers, alloys, shape memory alloys, etc. Other suitable materials known in the art may also be employed.

While FIG. 6 illustrates a single ablation transducer 610, it is contemplated that the modulation system 600 may include any number of ablation transducers desired, such as, but not limited to two, three, or more. The ablation transducer 610 is configured to deliver acoustic energy (i.e., ultrasound waves) to a target tissue. At the targeted tissue, the acoustic energy is converted to heat resulting in protein denaturation and coagulative necrosis of the tissue and/or nerves at the target region. In some instances, the frequency of the ultrasound energy used for the procedure may be set so that the ablated area of tissue starts after it passes through the vessel wall thereby minimizing potential heat damage of the vessel wall.

As shown, the ablation transducer 610 may have a hollow cylindrical shape that may define a lumen 609. The lumen 609 may remain in fluid communication with the first lumen 605 and the through holes 607. Those skilled in the art, however, will appreciate that any suitable shape such as, but not limited to, square, rectangular, polygonal, circular, oblong, or the like may also be contemplated.

While the ablation transducer 610 is described as an ultrasonic transducer, it is contemplated that other methods and devices for raising the temperature of the target tissue (e.g., nerve) may be used, such as, but not limited to: radiofrequency, microwave, other acoustic, optical, electrical current, direct contact heating, or other heating.

The ablation transducer 610 may be formed from any suitable material such as, but not limited to, lead zirconate titanate (PZT). It is contemplated that other ceramic or piezoelectric materials may also be used. In some instances, the ablation transducer 610 may include a layer of gold, or other conductive layer, disposed on the acoustically functional areas of the transducer 610 surface for connecting electrical leads to the ablation transducer 610. It is contemplated that the sides/edges of the transducer crystal may be free of conductive material so as not to “short circuit” the transducer 610. In some instances, one or more tie layers may be used to bond the gold to the PZT. For example, a layer of chrome may be disposed between the PZT and the gold to improve adhesion. In other instances, the transducer 610 may include a layer of chrome over the PZT followed by a layer of nickel, and finally a layer of gold. These are just examples. It is contemplated that the layers may be deposited on the PZT using sputter coating, although other deposition techniques may be used as desired.

Although not shown, the ablation transducer 610 may have a radiating surface, and a perimeter surface extending around the outer edge of the ablation transducer 610. The acoustic energy from the radiating surface of the ablation transducer 610 may be transmitted in a spatial pressure distribution related to the shape of the ablation transducer 610. For instance, the cylindrical shape of the ablation transducer 610 may provide a circumferential ablation pattern. In such an instance, the ablation transducer 610 may include a backing layer to direct the acoustic energy in a single direction. In other embodiments, the ablation transducer 610 may be structured to radiate acoustic energy from two radiating surfaces.

Further, the ablation transducer 610 can be operably coupled to the distal end 603 of the catheter shaft 602 through a first flexible mount member 606. As shown, the first flexible mount member 606 may have a generally trapezoidal shape, however, it should be noted that the flexible mount may take on any suitable shape such as rectangular, cylindrical, triangular, or the like. The first flexible mount member 606 may be affixed to the distal end 603 of the catheter shaft 602 at a proximal end 624, while being coupled to a proximal end 618 of the ablation transducer 610 at a distal end 626 thereof. In some instances, the first flexible mount 606 may include a proximal end 624 sized and shaped to be received within the lumen 605 of the catheter shaft 602, although this is not required. In some instances, the first flexible mount member 606 may be positioned along and secured to an outside surface of the catheter shaft 602. It is contemplated that the first flexible mount 606 may be secured to the catheter shaft 602 using any method desired, such as, but not limited to, adhesives, thermal bonding, heat shrinking, etc. The distal end 626 of the first flexible mount 606 may be secured to the proximal end 618 of the transducer 610 through a flexible adhesive 608a. In some instances, the flexible adhesive 608a may comprise silicone or other like materials.

Referring to FIGS. 6 and 7, the first flexible mount 606 may include a central lumen having an inner surface 628. The inner surface 628 may be fixedly secured to the proximal end 630 of the support mandrel 612 through any means desired. The first flexible mount 606 may further include one or more through holes 607a , 607b , 607c, 607d (collectively 607) extending from the proximal end 624 to the distal end 626 of the mount 606. For clarity, not all of the through holes 607 have been numbered in FIG. 7. The through holes 607 may be sized and shaped to allow an infusion fluid 614 to pass through the flexible mount 606. It is contemplated that the first flexible mount 606 may include any number of through holes desired, such as, but not limited to, one, two, three, four, or more. It is further contemplated that the through holes 607 may be arranged in any manner desired. For example, in some instances, the through holes 607 may be randomly scattered about the cross-section of the first flexible mount 606. In other instances, the through holes 607 may be arranged in a pattern. While FIG. 7 illustrates the through holes 607 as a single ring of holes, it is contemplated that there may be multiple rings (or other geometric configurations) across the cross-section of the first flexible mount 606. The through holes 607 may be in fluid communication with the first lumen 605 of the catheter shaft 602 and the lumen 609 of the transducer 610.

Further, the ablation transducer 610 can be operably coupled to the distal end 632 of the support mandrel 612 through a second flexible mount member 616. As shown, the second flexible mount member 616 may have a generally tapered proximal end 636 and a rounded atraumatic distal end 638, however, the second flexible mount may take on any suitable shape such as rectangular, cylindrical, triangular, or the like. The second flexible mount member 616 may be affixed to the distal end 622 of the ablation transducer 610 at a proximal end 636 thereof. The proximal end 636 of the second flexible mount 616 may be secured to the distal end 622 of the transducer 610 through a flexible adhesive 608b. In some instances, the flexible adhesive 608b may comprise silicone or other like materials.

The second flexible mount 616 may include a central lumen having an inner surface 634. The inner surface 634 may be fixedly secured to the distal end 632 of the support mandrel 612 through any means desired. The second flexible mount 616 may further include one or more through holes 615a , 615b (collectively 615) extending from the proximal end 636 to the distal end 638 of the mount 616. The through holes 615 may be sized and shaped to allow an infusion fluid 614 to pass through the flexible mount 616. It is contemplated that the second flexible mount 616 may include any number of through holes desired, such as, but not limited to, one, two, three, four, or more. number of through holes desired, such as, but not limited to, one, two, three, four, or more. It is further contemplated that the through holes 615 may be arranged in any manner desired. For example, in some instances, the through holes 615 may be randomly scattered about the cross-section of the second flexible mount 616. In other instances, the through holes 607 may be arranged in a pattern. The through holes 615 may be in fluid communication with the lumen 609 of the transducer 610 and may have a distal opening thus allowing the infusion fluid 614 to exit the system 600.

The support mandrel 612 may be configured to be disposed within the lumen 609 of the hollow cylindrical ablation transducer 610. As illustrated, the support mandrel may extend generally parallel with and along the length of the ablation transducer 610. As discussed above, the support mandrel 612 may be fixedly secured to inner lumens of the first and the second flexible mount members 606, 616. The flexible mounts 606, 616 may attached the transducer 610 to the support mandrel 612 to minimize interference with the transducer vibration. The support mandrel 612 may have a generally hollow cylindrical shape defining a lumen 611 extending from the proximal end 630 to the distal end 632 of the support mandrel 612. However, other suitable shapes of the support mandrel 612 including, for example, rectangular, irregular, or the like may also be contemplated. Further, the material employed to manufacture may include any suitable biocompatible material such as, but not limited to, metals, polymers, alloys, shape memory alloys or the like. The lumen 611 may be configured to receiving a guidewire 620 therethrough. In some embodiments, the lumen 611 may be in fluid communication with the lumen 605 of the catheter shaft 602 and thus some infusion fluid 614 may pass through lumen 611 and exit the system 600.

Saline or other suitable infusion fluid 614 may be flushed through the lumen 605 of the catheter shaft 602, through the through holes 607 of the first flexible mount 606, and into the lumen 609 of the transducer 610. The infusion fluid 614 may cool the transducer 610, reduce transducer damage, reduce surface fouling, reduce damage to the blood and other non-target tissue, and/or reduce overheating of the transducer 610 may be reduced or eliminated. The infusion fluid 614 may exit the system 600 via through holes 615 in the second flexible mount 616. It is contemplated that some infusion fluid 614 may also enter the lumen 611 of the support mandrel 613 from the lumen 605 of the catheter shaft 602 and exit the system via the distal end 632 of the support mandrel. In some instances, this may allow the modulation system 600 to be operated at a higher power level, thus providing a shorter treatment and/or more effective modulation of the target tissue. It is contemplated that the infusion fluid 614 may be introduced into the modulation system 600 before, during, or after ablation. Flow of the infusion fluid 614 may begin before energy is supplied to the ablation transducer 610 and continue for the duration of the modulation procedure.

Those skilled in the art will recognize that the present invention may be manifested in a variety of forms other than the specific embodiments described and contemplated herein. Accordingly, departure in form and detail may be made without departing from the scope and spirit of the present disclosure as described in the appended claims.

Claims

1. An intravascular nerve modulation system, comprising: an elongate shaft having a proximal end, a distal end, and an infusion lumen extending therebetween;an ablation transducer comprising an ultrasound transducer affixed to the elongate shaft adjacent the distal end thereof;an expandable basket having a proximal end and a distal end, the proximal end affixed to the elongate shaft proximal of a proximal end of the ablation transducer and the distal end is affixed to the elongate shaft distal of a distal end of the ablation transducer;an infusion sheath secured adjacent to the distal end of the elongate shaft in fluid communication with the infusion lumen, wherein the infusion sheath extends over the ablation transducer and is located within the expandable basket;wherein the system is configured to transport infusion fluid through the infusion lumen and past the ablation transducer thereby providing convective cooling to the ablation transducer; andwherein the expandable basket is configured to actuate between a first collapsed configuration and a second expanded configuration.
2. The nerve modulation system of claim 1, further comprising one or more temperature sensors coupled to the expandable basket.
3. The nerve modulation system of claim 1, wherein the expandable basket comprises two or more generally longitudinally extending struts.
4. The nerve modulation system of claim 1, further comprising a pull wire affixed to one of the distal end or the proximal end of the expandable basket.
5. The nerve modulation system of claim 4, wherein actuation of the pull wire moves the expandable basket between the first collapsed position and the second expanded position.
6. The nerve modulation system of claim 1, wherein the expandable basket is configured to self-expand.
7. The intravascular nerve modulation system at claim 1, wherein the elongate shaft comprises a first tubular member and a second tubular member and wherein said infusion lumen is located between the first tubular member and the second tubular member.
8. The intravascular nerve modulation system of claim 1, wherein the ablation transducer is a hollow ablation transducer that comprises a transducer lumen in fluid communication with the infusion lumen.
9. The intravascular nerve modulation system of claim 8, further comprising a flexible mount, wherein the ablation transducer is affixed to the elongate shaft through the flexible mount, and wherein the flexible mount comprises one or more lumens establishing fluid communication between the infusion lumen and the transducer lumen to allow the infusion fluid to be transported through the transducer lumen.
10. An intravascular nerve modulation system, comprising: an elongate shaft having a proximal end region, a distal end region and an infusion lumen extending therebetween;an ablation transducer comprising an ultrasound transducer coupled to the distal end region of the shaft;an expandable basket coupled to the distal end region of the shaft, the expandable basket having a proximal end disposed proximal of the ablation transducer and a distal end disposed distal of the ablation transducer;an infusion sheath secured adjacent to the distal end of the elongate shaft in fluid communication with the infusion lumen, wherein the infusion sheath extends over the ablation transducer and is located within the expandable basket;wherein the system is configured to transport infusion fluid through the infusion lumen and past the ablation transducer thereby providing convective cooling to the ablation transducer;wherein the expandable basket is capable of shifting between a first configuration and an expanded configuration;and a sensor coupled to the expandable basket.
11. The intravascular nerve modulation system claim 10, wherein the sensor includes a temperature sensor.
12. The intravascular nerve modulation system of claim 11, wherein the sensor is designed to monitor the temperature of a vessel wall during an ablation procedure.
13. The intravascular nerve modulation system claim 10, wherein the sensor includes an impedance sensor.
14. The intravascular nerve modulation system of claim 10, wherein the sensor is designed to contact a vessel wall during an ablation procedure.
15. The intravascular nerve modulation system of claim 10, wherein the sensor is designed to monitor the progress of an ablation procedure.
16. The intravascular nerve modulation system of claim 10, wherein the expandable basket includes a plurality of struts and wherein the sensor is coupled to one of the struts.
17. The intravascular nerve modulation system of claim 10, wherein a plurality of sensors are coupled to the expandable basket.
18. An intravascular nerve modulation system, comprising: an elongate shaft having a proximal end region, a distal end region and an infusion lumen extending therebetween;an ultrasound transducer coupled to the distal end region of the shaft;an expandable basket coupled to the distal end region of the shaft, the expandable basket having a proximal end disposed proximal of the ultrasound transducer and a distal end disposed distal of the ultrasound transducer;an infusion sheath secured adjacent to the distal end of the elongate shaft in fluid communication with the infusion lumen, wherein the infusion sheath extends over the ablation transducer and is located within the expandable basket;wherein the system is configured to transport infusion fluid through the infusion lumen and past the ablation transducer thereby providing convective cooling to the ablation transducer;wherein the expandable basket is capable of shifting between a first configuration and an expanded configuration;a sensor coupled to the expandable basket;wherein the sensor is capable of contacting a vessel wall when the basket is in the expanded configuration; and wherein the sensor is designed to monitor the progress of ablation by the ultrasound transducer during an ablation procedure.
19. The intravascular nerve modulation system claim 18, wherein the sensor includes a temperature sensor, an impedance sensor, or both.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority under 35 U.S.C. §119 to U.S. Provisional Application Ser. No. 61/891,241, filed Oct. 15, 2013, the entirety of which is incorporated herein by reference.

US Referenced Citations (1502)

Number	Name	Date	Kind
164184	Kidder	Jun 1875	A
852787	Hoerner	May 1907	A
921973	Gillett et al.	May 1909	A
976733	Gilliland	Nov 1910	A
1167014	O'Brien	Jan 1916	A
2505358	Gusberg et al.	Apr 1950	A
2701559	Cooper	Feb 1955	A
3108593	Glassman	Oct 1963	A
3108594	Glassman	Oct 1963	A
3540431	Mobin	Nov 1970	A
3952747	Kimmell	Apr 1976	A
3996938	Clark, III	Dec 1976	A
4046150	Schwartz et al.	Sep 1977	A
4290427	Chin	Sep 1981	A
4402686	Medel	Sep 1983	A
4483341	Witteles et al.	Nov 1984	A
4531943	Van Tassel et al.	Jul 1985	A
4574804	Kurwa	Mar 1986	A
4587975	Salo et al.	May 1986	A
4649936	Ungar et al.	Mar 1987	A
4682596	Bales et al.	Jul 1987	A
4709698	Johnston et al.	Dec 1987	A
4765331	Petruzzi et al.	Aug 1988	A
4770653	Shturman	Sep 1988	A
4784132	Fox et al.	Nov 1988	A
4784162	Ricks et al.	Nov 1988	A
4785806	Deckelbaum et al.	Nov 1988	A
4788975	Shturman et al.	Dec 1988	A
4790310	Ginsburg et al.	Dec 1988	A
4799479	Spears	Jan 1989	A
4823791	D'Amelio et al.	Apr 1989	A
4830003	Wolff et al.	May 1989	A
4849484	Heard	Jul 1989	A
4862886	Clarke et al.	Sep 1989	A
4887605	Angelsen et al.	Dec 1989	A
4890623	Cook et al.	Jan 1990	A
4920979	Bullara et al.	May 1990	A
4938766	Jarvik	Jul 1990	A
4955377	Lennox et al.	Sep 1990	A
4976711	Parins et al.	Dec 1990	A
5034010	Kittrell et al.	Jul 1991	A
5052402	Bencini et al.	Oct 1991	A
5053033	Clarke et al.	Oct 1991	A
5071424	Reger et al.	Dec 1991	A
5074871	Groshong et al.	Dec 1991	A
5098429	Sterzer et al.	Mar 1992	A
5098431	Rydell	Mar 1992	A
5109859	Jenkins	May 1992	A
5125928	Parins et al.	Jun 1992	A
5129396	Rosen et al.	Jul 1992	A
5139496	Hed	Aug 1992	A
5143836	Hartman et al.	Sep 1992	A
5156610	Reger et al.	Oct 1992	A
5158564	Schnepp-Pesch	Oct 1992	A
5170802	Mehra	Dec 1992	A
5178620	Eggers et al.	Jan 1993	A
5178625	Groshong et al.	Jan 1993	A
5190540	Lee	Mar 1993	A
5211651	Reger et al.	May 1993	A
5234407	Teirstein et al.	Aug 1993	A
5242441	Avitall	Sep 1993	A
5251634	Weinberg et al.	Oct 1993	A
5255679	Imran	Oct 1993	A
5263493	Avitall	Nov 1993	A
5267954	Nita et al.	Dec 1993	A
5277201	Stern et al.	Jan 1994	A
5282484	Reger et al.	Feb 1994	A
5286254	Shapland et al.	Feb 1994	A
5290306	Trotta et al.	Mar 1994	A
5295484	Marcus	Mar 1994	A
5297564	Love et al.	Mar 1994	A
5300068	Rosar et al.	Apr 1994	A
5301683	Durkan	Apr 1994	A
5304115	Pflueger et al.	Apr 1994	A
5304121	Sahatjian	Apr 1994	A
5304171	Gregory et al.	Apr 1994	A
5304173	Kittrell et al.	Apr 1994	A
5306250	March et al.	Apr 1994	A
5312328	Nita et al.	May 1994	A
5314466	Stern et al.	May 1994	A
5322064	Lundquist	Jun 1994	A
5324255	Passafaro et al.	Jun 1994	A
5326341	Lew et al.	Jul 1994	A
5326342	Plueger et al.	Jul 1994	A
5330518	Neilson et al.	Jul 1994	A
5333614	Feiring	Aug 1994	A
5342292	Nita et al.	Aug 1994	A
5344395	Whalen et al.	Sep 1994	A
5364392	Warner et al.	Nov 1994	A
5365172	Hrovat et al.	Nov 1994	A
5368557	Nita et al.	Nov 1994	A
5368558	Nita et al.	Nov 1994	A
5380274	Nita et al.	Jan 1995	A
5380319	Saito et al.	Jan 1995	A
5382228	Nita et al.	Jan 1995	A
5383874	Jackson et al.	Jan 1995	A
5383917	Desai et al.	Jan 1995	A
5397301	Pflueger et al.	Mar 1995	A
5397339	Desai	Mar 1995	A
5401272	Perkins et al.	Mar 1995	A
5403311	Abele et al.	Apr 1995	A
5405318	Nita et al.	Apr 1995	A
5405346	Grundy et al.	Apr 1995	A
5409000	Imran	Apr 1995	A
5417672	Nita et al.	May 1995	A
5419767	Eggers et al.	May 1995	A
5427118	Nita et al.	Jun 1995	A
5432876	Appeldorn et al.	Jul 1995	A
5441498	Perkins et al.	Aug 1995	A
5447509	Mills et al.	Sep 1995	A
5451207	Yock et al.	Sep 1995	A
5453091	Taylor et al.	Sep 1995	A
5454788	Walker et al.	Oct 1995	A
5454809	Janssen	Oct 1995	A
5455029	Hartman et al.	Oct 1995	A
5456682	Edwards et al.	Oct 1995	A
5457042	Hartman et al.	Oct 1995	A
5471982	Edwards et al.	Dec 1995	A
5474530	Passafaro et al.	Dec 1995	A
5478351	Meade et al.	Dec 1995	A
5496311	Abele et al.	Mar 1996	A
5496312	Klicek et al.	Mar 1996	A
5498261	Strul	Mar 1996	A
5505201	Grill et al.	Apr 1996	A
5505730	Edwards	Apr 1996	A
5507744	Tay et al.	Apr 1996	A
5512051	Wang et al.	Apr 1996	A
5522873	Jackman et al.	Jun 1996	A
5531520	Grimson et al.	Jul 1996	A
5540656	Pflueger et al.	Jul 1996	A
5540679	Fram et al.	Jul 1996	A
5540681	Strul et al.	Jul 1996	A
5542917	Nita et al.	Aug 1996	A
5545161	Imran	Aug 1996	A
5562100	Kittrell et al.	Oct 1996	A
5571122	Kelly et al.	Nov 1996	A
5571151	Gregory	Nov 1996	A
5573531	Gregory et al.	Nov 1996	A
5573533	Strul	Nov 1996	A
5584831	McKay	Dec 1996	A
5584872	Lafontaine et al.	Dec 1996	A
5588962	Nicholas et al.	Dec 1996	A
5599346	Edwards et al.	Feb 1997	A
5601526	Chapelon et al.	Feb 1997	A
5609606	O'Boyle et al.	Mar 1997	A
5613979	Trotta et al.	Mar 1997	A
5626576	Janssen	May 1997	A
5630837	Crowley	May 1997	A
5637090	McGee et al.	Jun 1997	A
5643255	Organ	Jul 1997	A
5643297	Nordgren et al.	Jul 1997	A
5647847	Lafontaine et al.	Jul 1997	A
5649923	Gregory et al.	Jul 1997	A
5651780	Jackson et al.	Jul 1997	A
5653684	Laptewicz et al.	Aug 1997	A
5662671	Barbut et al.	Sep 1997	A
5665062	Houser	Sep 1997	A
5665098	Kelly et al.	Sep 1997	A
5666964	Meilus	Sep 1997	A
5667490	Keith et al.	Sep 1997	A
5672174	Gough et al.	Sep 1997	A
5676693	Lafontaine	Oct 1997	A
5678296	Fleischhacker et al.	Oct 1997	A
5681282	Eggers et al.	Oct 1997	A
RE35656	Feinberg	Nov 1997	E
5687737	Branham et al.	Nov 1997	A
5688266	Edwards et al.	Nov 1997	A
5693015	Walker et al.	Dec 1997	A
5693029	Leonhardt et al.	Dec 1997	A
5693043	Kittrell et al.	Dec 1997	A
5693082	Warner et al.	Dec 1997	A
5695504	Gifford et al.	Dec 1997	A
5697369	Long, Jr. et al.	Dec 1997	A
5697909	Eggers et al.	Dec 1997	A
5702386	Stern et al.	Dec 1997	A
5702433	Taylor et al.	Dec 1997	A
5706809	Littmann et al.	Jan 1998	A
5713942	Stern et al.	Feb 1998	A
5715819	Svenson et al.	Feb 1998	A
5735846	Panescu et al.	Apr 1998	A
5741214	Ouchi et al.	Apr 1998	A
5741248	Stern et al.	Apr 1998	A
5741249	Moss et al.	Apr 1998	A
5743903	Stern et al.	Apr 1998	A
5748347	Erickson	May 1998	A
5749914	Janssen	May 1998	A
5755682	Knudson et al.	May 1998	A
5755715	Stern et al.	May 1998	A
5755753	Knowlton et al.	May 1998	A
5769847	Panescu et al.	Jun 1998	A
5769880	Truckai et al.	Jun 1998	A
5775338	Hastings	Jul 1998	A
5776174	Van Tassel	Jul 1998	A
5779698	Clayman et al.	Jul 1998	A
5782760	Schaer	Jul 1998	A
5785702	Murphy et al.	Jul 1998	A
5797849	Vesely et al.	Aug 1998	A
5797903	Swanson et al.	Aug 1998	A
5800484	Gough et al.	Sep 1998	A
5800494	Campbell et al.	Sep 1998	A
5807306	Shapland et al.	Sep 1998	A
5810802	Panescu et al.	Sep 1998	A
5810803	Moss et al.	Sep 1998	A
5810810	Tay et al.	Sep 1998	A
5817092	Behl	Oct 1998	A
5817113	Gifford et al.	Oct 1998	A
5817144	Gregory et al.	Oct 1998	A
5823956	Roth et al.	Oct 1998	A
5827203	Nita et al.	Oct 1998	A
5827268	Laufer	Oct 1998	A
5829447	Stevens et al.	Nov 1998	A
5830213	Panescu et al.	Nov 1998	A
5830222	Makower	Nov 1998	A
5832228	Holden et al.	Nov 1998	A
5833593	Liprie	Nov 1998	A
5836874	Swanson et al.	Nov 1998	A
5840076	Swanson et al.	Nov 1998	A
5843016	Lugnani et al.	Dec 1998	A
5846238	Jackson et al.	Dec 1998	A
5846239	Swanson et al.	Dec 1998	A
5846245	McCarthy et al.	Dec 1998	A
5848969	Panescu et al.	Dec 1998	A
5853411	Whayne et al.	Dec 1998	A
5855614	Stevens et al.	Jan 1999	A
5860974	Abele	Jan 1999	A
5865801	Houser	Feb 1999	A
5868735	Lafontaine et al.	Feb 1999	A
5868736	Swanson et al.	Feb 1999	A
5871483	Jackson et al.	Feb 1999	A
5871524	Knowlton et al.	Feb 1999	A
5875782	Ferrari et al.	Mar 1999	A
5876369	Houser	Mar 1999	A
5876374	Alba et al.	Mar 1999	A
5876397	Edelman et al.	Mar 1999	A
5879348	Owens et al.	Mar 1999	A
5891114	Chien et al.	Apr 1999	A
5891135	Jackson et al.	Apr 1999	A
5891136	McGee et al.	Apr 1999	A
5891138	Tu et al.	Apr 1999	A
5895378	Nita	Apr 1999	A
5897552	Edwards et al.	Apr 1999	A
5902328	Lafontaine et al.	May 1999	A
5904651	Swanson et al.	May 1999	A
5904667	Falwell et al.	May 1999	A
5904697	Gifford, III et al.	May 1999	A
5904709	Arndt et al.	May 1999	A
5906614	Stern et al.	May 1999	A
5906623	Peterson	May 1999	A
5906636	Casscells et al.	May 1999	A
5916192	Nita et al.	Jun 1999	A
5916227	Keith et al.	Jun 1999	A
5916239	Geddes et al.	Jun 1999	A
5919219	Knowlton et al.	Jul 1999	A
5924424	Stevens et al.	Jul 1999	A
5925038	Panescu et al.	Jul 1999	A
5934284	Plaia et al.	Aug 1999	A
5935063	Nguyen	Aug 1999	A
5938670	Keith et al.	Aug 1999	A
5947977	Slepian et al.	Sep 1999	A
5948011	Knowlton et al.	Sep 1999	A
5951494	Wang et al.	Sep 1999	A
5951539	Nita et al.	Sep 1999	A
5954717	Behl et al.	Sep 1999	A
5957882	Nita et al.	Sep 1999	A
5957941	Ream et al.	Sep 1999	A
5957969	Warner et al.	Sep 1999	A
5961513	Swanson et al.	Oct 1999	A
5964757	Ponzi et al.	Oct 1999	A
5967976	Larsen et al.	Oct 1999	A
5967978	Littmann et al.	Oct 1999	A
5967984	Chu et al.	Oct 1999	A
5971975	Mills et al.	Oct 1999	A
5972026	Laufer et al.	Oct 1999	A
5980563	Tu et al.	Nov 1999	A
5989208	Nita et al.	Nov 1999	A
5989284	Laufer	Nov 1999	A
5993462	Pomeranz et al.	Nov 1999	A
5997497	Nita et al.	Dec 1999	A
5999678	Murphy et al.	Dec 1999	A
6004269	Crowley et al.	Dec 1999	A
6004316	Laufer et al.	Dec 1999	A
6007514	Nita	Dec 1999	A
6010522	Barbut et al.	Jan 2000	A
6013033	Berger et al.	Jan 2000	A
6014590	Whayne et al.	Jan 2000	A
6022309	Celliers et al.	Feb 2000	A
6024740	Lesh et al.	Feb 2000	A
6030611	Gorecki et al.	Feb 2000	A
6032675	Rubinsky et al.	Mar 2000	A
6033397	Laufer et al.	Mar 2000	A
6033398	Farley et al.	Mar 2000	A
6036687	Laufer et al.	Mar 2000	A
6036689	Tu et al.	Mar 2000	A
6041260	Stern et al.	Mar 2000	A
6050994	Sherman et al.	Apr 2000	A
6056744	Edwards	May 2000	A
6056746	Goble et al.	May 2000	A
6063085	Tay et al.	May 2000	A
6066096	Smith et al.	May 2000	A
6066139	Ryan et al.	May 2000	A
6068638	Makower	May 2000	A
6068653	Lafontaine	May 2000	A
6071277	Farley et al.	Jun 2000	A
6071278	Panescu et al.	Jun 2000	A
6078839	Carson	Jun 2000	A
6079414	Roth	Jun 2000	A
6080171	Keith et al.	Jun 2000	A
6081749	Ingle et al.	Jun 2000	A
6086581	Reynolds et al.	Jul 2000	A
6091995	Ingle et al.	Jul 2000	A
6093166	Knudson et al.	Jul 2000	A
6096021	Helm et al.	Aug 2000	A
6099526	Whayne et al.	Aug 2000	A
6102908	Tu et al.	Aug 2000	A
6106477	Miesel et al.	Aug 2000	A
6110187	Donlon et al.	Aug 2000	A
6110192	Ravenscroft et al.	Aug 2000	A
6114311	Parmacek et al.	Sep 2000	A
6117101	Diederich et al.	Sep 2000	A
6117128	Gregory	Sep 2000	A
6120476	Fung et al.	Sep 2000	A
6120516	Selmon et al.	Sep 2000	A
6121775	Pearlman	Sep 2000	A
6123679	Lafaut et al.	Sep 2000	A
6123682	Knudson et al.	Sep 2000	A
6123702	Swanson et al.	Sep 2000	A
6123703	Tu et al.	Sep 2000	A
6123718	Tu et al.	Sep 2000	A
6129725	Tu et al.	Oct 2000	A
6135997	Laufer et al.	Oct 2000	A
6142991	Schatzberger et al.	Nov 2000	A
6142993	Whayne et al.	Nov 2000	A
6149647	Tu et al.	Nov 2000	A
6152899	Farley et al.	Nov 2000	A
6152912	Jansen et al.	Nov 2000	A
6156046	Passafaro et al.	Dec 2000	A
6158250	Tibbals et al.	Dec 2000	A
6159187	Park et al.	Dec 2000	A
6159225	Makower	Dec 2000	A
6161048	Sluijter et al.	Dec 2000	A
6162184	Swanson et al.	Dec 2000	A
6165163	Chien et al.	Dec 2000	A
6165172	Farley et al.	Dec 2000	A
6165187	Reger et al.	Dec 2000	A
6168594	Lafontaine et al.	Jan 2001	B1
6171321	Gifford, III et al.	Jan 2001	B1
6179832	Jones et al.	Jan 2001	B1
6179835	Panescu et al.	Jan 2001	B1
6179859	Bates et al.	Jan 2001	B1
6183468	Swanson et al.	Feb 2001	B1
6183486	Snow et al.	Feb 2001	B1
6190379	Heuser et al.	Feb 2001	B1
6191862	Swanson et al.	Feb 2001	B1
6197021	Panescu et al.	Mar 2001	B1
6200266	Shokrollahi et al.	Mar 2001	B1
6203537	Adrian	Mar 2001	B1
6203561	Ramee et al.	Mar 2001	B1
6210406	Webster	Apr 2001	B1
6211247	Goodman	Apr 2001	B1
6217576	Tu et al.	Apr 2001	B1
6219577	Brown, III et al.	Apr 2001	B1
6228076	Winston et al.	May 2001	B1
6228109	Tu et al.	May 2001	B1
6231516	Keilman et al.	May 2001	B1
6231587	Makower	May 2001	B1
6235044	Root et al.	May 2001	B1
6236883	Ciaccio et al.	May 2001	B1
6237605	Vaska et al.	May 2001	B1
6238389	Paddock et al.	May 2001	B1
6238392	Long	May 2001	B1
6241666	Pomeranz et al.	Jun 2001	B1
6241753	Knowlton	Jun 2001	B1
6245020	Moore et al.	Jun 2001	B1
6245045	Stratienko	Jun 2001	B1
6248126	Lesser et al.	Jun 2001	B1
6251128	Knopp et al.	Jun 2001	B1
6258087	Edwards et al.	Jul 2001	B1
6273886	Edwards et al.	Aug 2001	B1
6280466	Kugler et al.	Aug 2001	B1
6283935	Laufer et al.	Sep 2001	B1
6283959	Lalonde et al.	Sep 2001	B1
6284743	Parmacek et al.	Sep 2001	B1
6287323	Hammerslag	Sep 2001	B1
6290696	Lafontaine	Sep 2001	B1
6292695	Webster, Jr. et al.	Sep 2001	B1
6293942	Goble et al.	Sep 2001	B1
6293943	Panescu et al.	Sep 2001	B1
6296619	Brisken et al.	Oct 2001	B1
6298256	Meyer	Oct 2001	B1
6299379	Lewis	Oct 2001	B1
6299623	Wulfman	Oct 2001	B1
6309379	Willard et al.	Oct 2001	B1
6309399	Barbut et al.	Oct 2001	B1
6311090	Knowlton	Oct 2001	B1
6317615	KenKnight et al.	Nov 2001	B1
6319242	Patterson et al.	Nov 2001	B1
6319251	Tu et al.	Nov 2001	B1
6322559	Daulton et al.	Nov 2001	B1
6325797	Stewart et al.	Dec 2001	B1
6325799	Goble	Dec 2001	B1
6328699	Eigler et al.	Dec 2001	B1
6346074	Roth	Feb 2002	B1
6346104	Daly et al.	Feb 2002	B2
6350248	Knudson et al.	Feb 2002	B1
6350276	Knowlton	Feb 2002	B1
6353751	Swanson et al.	Mar 2002	B1
6355029	Joye et al.	Mar 2002	B1
6357447	Swanson et al.	Mar 2002	B1
6361519	Knudson et al.	Mar 2002	B1
6364840	Crowley	Apr 2002	B1
6371965	Gifford, III et al.	Apr 2002	B2
6375668	Gifford et al.	Apr 2002	B1
6377854	Knowlton	Apr 2002	B1
6377855	Knowlton	Apr 2002	B1
6379352	Reynolds et al.	Apr 2002	B1
6379373	Sawhney et al.	Apr 2002	B1
6381497	Knowlton	Apr 2002	B1
6381498	Knowlton	Apr 2002	B1
6383151	Diederich et al.	May 2002	B1
6387105	Gifford, III et al.	May 2002	B1
6387380	Knowlton	May 2002	B1
6389311	Whayne et al.	May 2002	B1
6389314	Feiring	May 2002	B2
6391024	Sun et al.	May 2002	B1
6394096	Constantz	May 2002	B1
6394956	Chandrasekaran et al.	May 2002	B1
6398780	Farley et al.	Jun 2002	B1
6398782	Pecor et al.	Jun 2002	B1
6398792	O'Connor	Jun 2002	B1
6401720	Stevens et al.	Jun 2002	B1
6402719	Ponzi et al.	Jun 2002	B1
6405090	Knowlton	Jun 2002	B1
6409723	Edwards	Jun 2002	B1
6413255	Stern	Jul 2002	B1
6421559	Pearlman	Jul 2002	B1
6423057	He et al.	Jul 2002	B1
6425867	Vaezy et al.	Jul 2002	B1
6425912	Knowlton	Jul 2002	B1
6427118	Suzuki	Jul 2002	B1
6428534	Joye et al.	Aug 2002	B1
6428536	Panescu et al.	Aug 2002	B2
6430446	Knowlton	Aug 2002	B1
6432102	Joye et al.	Aug 2002	B2
6436056	Wang et al.	Aug 2002	B1
6438424	Knowlton	Aug 2002	B1
6440125	Rentrop	Aug 2002	B1
6442413	Silver	Aug 2002	B1
6443965	Gifford, III et al.	Sep 2002	B1
6445939	Swanson et al.	Sep 2002	B1
6447505	McGovern et al.	Sep 2002	B2
6447509	Bonnet et al.	Sep 2002	B1
6451034	Gifford, III et al.	Sep 2002	B1
6451044	Naghavi et al.	Sep 2002	B1
6453202	Knowlton	Sep 2002	B1
6454737	Nita et al.	Sep 2002	B1
6454757	Nita et al.	Sep 2002	B1
6454775	Demarais et al.	Sep 2002	B1
6458098	Kanesaka	Oct 2002	B1
6461378	Knowlton	Oct 2002	B1
6468276	McKay	Oct 2002	B1
6468297	Williams et al.	Oct 2002	B1
6470216	Knowlton	Oct 2002	B1
6470219	Edwards et al.	Oct 2002	B1
6471696	Berube et al.	Oct 2002	B1
6475213	Whayne et al.	Nov 2002	B1
6475215	Tanrisever	Nov 2002	B1
6475238	Fedida et al.	Nov 2002	B1
6477426	Fenn et al.	Nov 2002	B1
6480745	Nelson et al.	Nov 2002	B2
6481704	Koster et al.	Nov 2002	B1
6482202	Goble et al.	Nov 2002	B1
6484052	Visuri et al.	Nov 2002	B1
6485489	Teirstein et al.	Nov 2002	B2
6488679	Swanson et al.	Dec 2002	B1
6489307	Phillips et al.	Dec 2002	B1
6491705	Gifford, III et al.	Dec 2002	B2
6494891	Cornish et al.	Dec 2002	B1
6497711	Plaia et al.	Dec 2002	B1
6500172	Panescu et al.	Dec 2002	B1
6500174	Maguire et al.	Dec 2002	B1
6508765	Suorsa et al.	Jan 2003	B2
6508804	Sarge et al.	Jan 2003	B2
6508815	Strul et al.	Jan 2003	B1
6511478	Burnside et al.	Jan 2003	B1
6511496	Huter et al.	Jan 2003	B1
6511500	Rahme	Jan 2003	B1
6514236	Stratienko	Feb 2003	B1
6514245	Williams et al.	Feb 2003	B1
6514248	Eggers et al.	Feb 2003	B1
6517534	McGovern et al.	Feb 2003	B1
6517572	Kugler et al.	Feb 2003	B2
6522913	Swanson et al.	Feb 2003	B2
6522926	Kieval et al.	Feb 2003	B1
6524299	Tran et al.	Feb 2003	B1
6527765	Kelman et al.	Mar 2003	B2
6527769	Langberg et al.	Mar 2003	B2
6540761	Houser	Apr 2003	B2
6542781	Koblish et al.	Apr 2003	B1
6544780	Wang	Apr 2003	B1
6546272	MacKinnon et al.	Apr 2003	B1
6547788	Maguire et al.	Apr 2003	B1
6549800	Atalar et al.	Apr 2003	B1
6552796	Magnin et al.	Apr 2003	B2
6554780	Sampson et al.	Apr 2003	B1
6558381	Ingle et al.	May 2003	B2
6558382	Jahns et al.	May 2003	B2
6564096	Mest	May 2003	B2
6565582	Gifford, III et al.	May 2003	B2
6569109	Sakurai et al.	May 2003	B2
6569177	Dillard et al.	May 2003	B1
6570659	Schmitt	May 2003	B2
6572551	Smith et al.	Jun 2003	B1
6572612	Stewart et al.	Jun 2003	B2
6577902	Laufer et al.	Jun 2003	B1
6579308	Jansen et al.	Jun 2003	B1
6579311	Makower	Jun 2003	B1
6582423	Thapliyal et al.	Jun 2003	B1
6589238	Edwards et al.	Jul 2003	B2
6592526	Lenker	Jul 2003	B1
6592567	Levin et al.	Jul 2003	B1
6595959	Stratienko	Jul 2003	B1
6600956	Maschino et al.	Jul 2003	B2
6602242	Fung et al.	Aug 2003	B1
6602246	Joye et al.	Aug 2003	B1
6605056	Eidenschink et al.	Aug 2003	B2
6605084	Acker et al.	Aug 2003	B2
6623452	Chien et al.	Sep 2003	B2
6623453	Guibert et al.	Sep 2003	B1
6632193	Davison et al.	Oct 2003	B1
6632196	Houser	Oct 2003	B1
6645223	Boyle et al.	Nov 2003	B2
6648854	Patterson et al.	Nov 2003	B1
6648878	Lafontaine	Nov 2003	B2
6648879	Joye et al.	Nov 2003	B2
6651672	Roth	Nov 2003	B2
6652513	Panescu et al.	Nov 2003	B2
6652515	Maguire et al.	Nov 2003	B1
6656136	Weng et al.	Dec 2003	B1
6658279	Swanson et al.	Dec 2003	B2
6659981	Stewart et al.	Dec 2003	B2
6666858	Lafontaine	Dec 2003	B2
6666863	Wentzel et al.	Dec 2003	B2
6669655	Acker et al.	Dec 2003	B1
6669692	Nelson et al.	Dec 2003	B1
6673040	Samson et al.	Jan 2004	B1
6673064	Rentrop	Jan 2004	B1
6673066	Werneth	Jan 2004	B2
6673090	Root et al.	Jan 2004	B2
6673101	Fitzgerald et al.	Jan 2004	B1
6673290	Whayne et al.	Jan 2004	B1
6676678	Gifford, III et al.	Jan 2004	B2
6679268	Stevens et al.	Jan 2004	B2
6681773	Murphy et al.	Jan 2004	B2
6682541	Gifford, III et al.	Jan 2004	B1
6684098	Oshio et al.	Jan 2004	B2
6685732	Kramer	Feb 2004	B2
6685733	Dae et al.	Feb 2004	B1
6689086	Nita et al.	Feb 2004	B1
6689148	Sawhney et al.	Feb 2004	B2
6690181	Dowdeswell et al.	Feb 2004	B1
6692490	Edwards	Feb 2004	B1
6695830	Vigil et al.	Feb 2004	B2
6695857	Gifford, III et al.	Feb 2004	B2
6699241	Rappaport et al.	Mar 2004	B2
6699257	Gifford, III et al.	Mar 2004	B2
6702748	Nita et al.	Mar 2004	B1
6702811	Stewart et al.	Mar 2004	B2
6706010	Miki et al.	Mar 2004	B1
6706011	Murphy-Chutorian et al.	Mar 2004	B1
6706037	Zvuloni et al.	Mar 2004	B2
6709431	Lafontaine	Mar 2004	B2
6711429	Gilboa et al.	Mar 2004	B1
6712815	Sampson et al.	Mar 2004	B2
6714822	King et al.	Mar 2004	B2
6716184	Vaezy et al.	Apr 2004	B2
6720350	Kunz et al.	Apr 2004	B2
6723043	Kleeman et al.	Apr 2004	B2
6723064	Babaev	Apr 2004	B2
6736811	Panescu et al.	May 2004	B2
6743184	Sampson et al.	Jun 2004	B2
6746401	Panescu	Jun 2004	B2
6746464	Makower	Jun 2004	B1
6746474	Saadat	Jun 2004	B2
6748953	Sherry et al.	Jun 2004	B2
6749607	Edwards et al.	Jun 2004	B2
6752805	Maguire et al.	Jun 2004	B2
6760616	Hoey et al.	Jul 2004	B2
6763261	Casscells, III et al.	Jul 2004	B2
6764501	Ganz	Jul 2004	B2
6769433	Zikorus et al.	Aug 2004	B2
6770070	Balbierz	Aug 2004	B1
6771996	Bowe et al.	Aug 2004	B2
6773433	Stewart et al.	Aug 2004	B2
6786900	Joye et al.	Sep 2004	B2
6786901	Joye et al.	Sep 2004	B2
6786904	Döscher et al.	Sep 2004	B2
6788977	Fenn et al.	Sep 2004	B2
6790206	Panescu	Sep 2004	B2
6790222	Kugler et al.	Sep 2004	B2
6796981	Wham et al.	Sep 2004	B2
6797933	Mendis et al.	Sep 2004	B1
6797960	Spartiotis et al.	Sep 2004	B1
6800075	Mische et al.	Oct 2004	B2
6802857	Walsh et al.	Oct 2004	B1
6807444	Tu et al.	Oct 2004	B2
6811550	Holland et al.	Nov 2004	B2
6813520	Truckai et al.	Nov 2004	B2
6814730	Li	Nov 2004	B2
6814733	Schwartz et al.	Nov 2004	B2
6823205	Jara	Nov 2004	B1
6824516	Batten et al.	Nov 2004	B2
6827726	Parodi	Dec 2004	B2
6827926	Robinson et al.	Dec 2004	B2
6829497	Mogul	Dec 2004	B2
6830568	Kesten et al.	Dec 2004	B1
6837886	Collins et al.	Jan 2005	B2
6837888	Ciarrocca et al.	Jan 2005	B2
6845267	Harrison	Jan 2005	B2
6847848	Sterzer	Jan 2005	B2
6849073	Hoey et al.	Feb 2005	B2
6849075	Bertolero et al.	Feb 2005	B2
6853425	Kim et al.	Feb 2005	B2
6855123	Nita	Feb 2005	B2
6855143	Davison	Feb 2005	B2
6869431	Maguire et al.	Mar 2005	B2
6872183	Sampson et al.	Mar 2005	B2
6884260	Kugler et al.	Apr 2005	B2
6889694	Hooven	May 2005	B2
6893436	Woodard et al.	May 2005	B2
6895077	Karellas et al.	May 2005	B2
6895265	Silver	May 2005	B2
6898454	Atalar et al.	May 2005	B2
6899711	Stewart et al.	May 2005	B2
6899718	Gifford, III et al.	May 2005	B2
6905494	Yon et al.	Jun 2005	B2
6908462	Joye et al.	Jun 2005	B2
6909009	Koridze	Jun 2005	B2
6911026	Hall et al.	Jun 2005	B1
6915806	Pacek et al.	Jul 2005	B2
6923805	LaFontaine et al.	Aug 2005	B1
6923808	Taimisto	Aug 2005	B2
6926246	Ginggen	Aug 2005	B2
6926713	Rioux et al.	Aug 2005	B2
6926716	Baker et al.	Aug 2005	B2
6929009	Makower et al.	Aug 2005	B2
6929632	Nita et al.	Aug 2005	B2
6929639	Lafontaine	Aug 2005	B2
6932776	Carr	Aug 2005	B2
6936047	Nasab et al.	Aug 2005	B2
6942620	Nita et al.	Sep 2005	B2
6942657	Sinofsky et al.	Sep 2005	B2
6942677	Nita et al.	Sep 2005	B2
6942692	Landau et al.	Sep 2005	B2
6949097	Stewart et al.	Sep 2005	B2
6949121	Laguna	Sep 2005	B1
6952615	Satake	Oct 2005	B2
6953425	Brister	Oct 2005	B2
6955174	Joye et al.	Oct 2005	B2
6955175	Stevens et al.	Oct 2005	B2
6959711	Murphy et al.	Nov 2005	B2
6960207	Vanney et al.	Nov 2005	B2
6962584	Stone et al.	Nov 2005	B1
6964660	Maguire et al.	Nov 2005	B2
6966908	Maguire et al.	Nov 2005	B2
6972015	Joye et al.	Dec 2005	B2
6972024	Kilpatrick et al.	Dec 2005	B1
6974456	Edwards et al.	Dec 2005	B2
6978174	Gelfand et al.	Dec 2005	B2
6979329	Burnside et al.	Dec 2005	B2
6979420	Weber	Dec 2005	B2
6984238	Gifford, III et al.	Jan 2006	B2
6985774	Kieval et al.	Jan 2006	B2
6986739	Warren et al.	Jan 2006	B2
6989009	Lafontaine	Jan 2006	B2
6989010	Francischelli et al.	Jan 2006	B2
6991617	Hektner et al.	Jan 2006	B2
7001378	Yon et al.	Feb 2006	B2
7006858	Silver et al.	Feb 2006	B2
7022105	Edwards	Apr 2006	B1
7022120	Lafontaine	Apr 2006	B2
7025767	Schaefer et al.	Apr 2006	B2
7033322	Silver	Apr 2006	B2
7033372	Cahalan	Apr 2006	B1
7041098	Farley et al.	May 2006	B2
7050848	Hoey et al.	May 2006	B2
7063670	Sampson et al.	Jun 2006	B2
7063679	Maguire et al.	Jun 2006	B2
7063719	Jansen et al.	Jun 2006	B2
7066895	Podany	Jun 2006	B2
7066900	Botto et al.	Jun 2006	B2
7066904	Rosenthal et al.	Jun 2006	B2
7072720	Puskas	Jul 2006	B2
7074217	Strul et al.	Jul 2006	B2
7081112	Joye et al.	Jul 2006	B2
7081114	Rashidi	Jul 2006	B2
7083614	Fjield et al.	Aug 2006	B2
7084276	Vu et al.	Aug 2006	B2
7087026	Callister et al.	Aug 2006	B2
7087051	Bourne et al.	Aug 2006	B2
7087052	Sampson et al.	Aug 2006	B2
7087053	Vanney	Aug 2006	B2
7089065	Westlund et al.	Aug 2006	B2
7097641	Arless et al.	Aug 2006	B1
7100614	Stevens et al.	Sep 2006	B2
7101368	Lafontaine	Sep 2006	B2
7104983	Grasso, III et al.	Sep 2006	B2
7104987	Biggs et al.	Sep 2006	B2
7108715	Lawrence-Brown et al.	Sep 2006	B2
7112196	Brosch et al.	Sep 2006	B2
7112198	Satake	Sep 2006	B2
7112211	Gifford, III et al.	Sep 2006	B2
7122019	Kesten et al.	Oct 2006	B1
7122033	Wood	Oct 2006	B2
7134438	Makower et al.	Nov 2006	B2
7137963	Nita et al.	Nov 2006	B2
7137980	Buysse et al.	Nov 2006	B2
7153315	Miller	Dec 2006	B2
7155271	Halperin et al.	Dec 2006	B2
7157491	Mewshaw et al.	Jan 2007	B2
7157492	Mewshaw et al.	Jan 2007	B2
7158832	Kieval et al.	Jan 2007	B2
7160296	Pearson et al.	Jan 2007	B2
7162303	Levin et al.	Jan 2007	B2
7165551	Edwards et al.	Jan 2007	B2
7169144	Hoey et al.	Jan 2007	B2
7172589	Lafontaine	Feb 2007	B2
7172610	Heitzmann et al.	Feb 2007	B2
7181261	Silver et al.	Feb 2007	B2
7184811	Phan et al.	Feb 2007	B2
7184827	Edwards	Feb 2007	B1
7189227	Lafontaine	Mar 2007	B2
7192427	Chapelon et al.	Mar 2007	B2
7192586	Bander	Mar 2007	B2
7197354	Sobe	Mar 2007	B2
7198632	Lim et al.	Apr 2007	B2
7200445	Dalbec et al.	Apr 2007	B1
7201749	Govari et al.	Apr 2007	B2
7203537	Mower	Apr 2007	B2
7214234	Rapacki et al.	May 2007	B2
7220233	Nita et al.	May 2007	B2
7220239	Wilson et al.	May 2007	B2
7220257	Lafontaine	May 2007	B1
7220270	Sawhney et al.	May 2007	B2
7232458	Saadat	Jun 2007	B2
7232459	Greenberg et al.	Jun 2007	B2
7238184	Megerman et al.	Jul 2007	B2
7241273	Maguire et al.	Jul 2007	B2
7241736	Hunter et al.	Jul 2007	B2
7247141	Makin et al.	Jul 2007	B2
7250041	Chiu et al.	Jul 2007	B2
7250440	Mewshaw et al.	Jul 2007	B2
7252664	Nasab et al.	Aug 2007	B2
7252679	Fischell et al.	Aug 2007	B2
7264619	Venturelli	Sep 2007	B2
7279600	Mewshaw et al.	Oct 2007	B2
7280863	Shachar	Oct 2007	B2
7282213	Schroeder et al.	Oct 2007	B2
7285119	Stewart et al.	Oct 2007	B2
7285120	Im et al.	Oct 2007	B2
7288089	Yon et al.	Oct 2007	B2
7288096	Chin	Oct 2007	B2
7291146	Steinke et al.	Nov 2007	B2
7293562	Malecki et al.	Nov 2007	B2
7294125	Phalen et al.	Nov 2007	B2
7294126	Sampson et al.	Nov 2007	B2
7294127	Leung et al.	Nov 2007	B2
7297131	Nita	Nov 2007	B2
7297475	Koiwai et al.	Nov 2007	B2
7300433	Lane et al.	Nov 2007	B2
7301108	Egitto et al.	Nov 2007	B2
7310150	Guillermo et al.	Dec 2007	B2
7313430	Urquhart et al.	Dec 2007	B2
7314480	Eidenschink et al.	Jan 2008	B2
7314483	Landau et al.	Jan 2008	B2
7317077	Averback et al.	Jan 2008	B2
7323006	Andreas et al.	Jan 2008	B2
7326206	Paul et al.	Feb 2008	B2
7326226	Root et al.	Feb 2008	B2
7326235	Edwards	Feb 2008	B2
7326237	DePalma et al.	Feb 2008	B2
7329236	Kesten et al.	Feb 2008	B2
7335180	Nita et al.	Feb 2008	B2
7335192	Keren et al.	Feb 2008	B2
7338467	Lutter	Mar 2008	B2
7341570	Keren et al.	Mar 2008	B2
7343195	Strommer et al.	Mar 2008	B2
7347857	Anderson et al.	Mar 2008	B2
7348003	Salcedo et al.	Mar 2008	B2
7352593	Zeng et al.	Apr 2008	B2
7354927	Vu	Apr 2008	B2
7359732	Kim et al.	Apr 2008	B2
7361341	Salcedo et al.	Apr 2008	B2
7364566	Elkins et al.	Apr 2008	B2
7367970	Govari et al.	May 2008	B2
7367975	Malecki et al.	May 2008	B2
7371231	Rioux et al.	May 2008	B2
7387126	Cox et al.	Jun 2008	B2
7393338	Nita	Jul 2008	B2
7396355	Goldman et al.	Jul 2008	B2
7402151	Rosenman et al.	Jul 2008	B2
7402312	Rosen et al.	Jul 2008	B2
7404824	Webler et al.	Jul 2008	B1
7406970	Zikorus et al.	Aug 2008	B2
7407502	Strul et al.	Aug 2008	B2
7407506	Makower	Aug 2008	B2
7407671	McBride et al.	Aug 2008	B2
7408021	Averback et al.	Aug 2008	B2
7410486	Fuimaono et al.	Aug 2008	B2
7413556	Zhang et al.	Aug 2008	B2
7425212	Danek et al.	Sep 2008	B1
7426409	Casscells, III et al.	Sep 2008	B2
7435248	Taimisto et al.	Oct 2008	B2
7447453	Kim et al.	Nov 2008	B2
7449018	Kramer	Nov 2008	B2
7452538	Ni et al.	Nov 2008	B2
7473890	Grier et al.	Jan 2009	B2
7476384	Ni et al.	Jan 2009	B2
7479157	Weber et al.	Jan 2009	B2
7481803	Kesten et al.	Jan 2009	B2
7485104	Kieval	Feb 2009	B2
7486805	Krattiger	Feb 2009	B2
7487780	Hooven	Feb 2009	B2
7493154	Bonner et al.	Feb 2009	B2
7494485	Beck et al.	Feb 2009	B2
7494486	Mische et al.	Feb 2009	B2
7494488	Weber	Feb 2009	B2
7494661	Sanders	Feb 2009	B2
7495439	Wiggins	Feb 2009	B2
7497858	Chapelon et al.	Mar 2009	B2
7499745	Littrup et al.	Mar 2009	B2
7500985	Saadat	Mar 2009	B2
7505812	Eggers et al.	Mar 2009	B1
7505816	Schmeling et al.	Mar 2009	B2
7507233	Littrup et al.	Mar 2009	B2
7507235	Keogh et al.	Mar 2009	B2
7511494	Wedeen	Mar 2009	B2
7512445	Truckai et al.	Mar 2009	B2
7527643	Case et al.	May 2009	B2
7529589	Williams et al.	May 2009	B2
7540852	Nita et al.	Jun 2009	B2
7540870	Babaev	Jun 2009	B2
RE40863	Tay et al.	Jul 2009	E
7556624	Laufer et al.	Jul 2009	B2
7558625	Levin et al.	Jul 2009	B2
7563247	Maguire et al.	Jul 2009	B2
7566319	McAuley et al.	Jul 2009	B2
7569052	Phan et al.	Aug 2009	B2
7582111	Krolik et al.	Sep 2009	B2
7584004	Caparso et al.	Sep 2009	B2
7585835	Hill et al.	Sep 2009	B2
7591996	Hwang et al.	Sep 2009	B2
7597704	Frazier et al.	Oct 2009	B2
7598228	Hattori et al.	Oct 2009	B2
7599730	Hunter et al.	Oct 2009	B2
7603166	Casscells, III et al.	Oct 2009	B2
7604608	Nita et al.	Oct 2009	B2
7604633	Truckai et al.	Oct 2009	B2
7615015	Coleman	Nov 2009	B2
7615072	Rust et al.	Nov 2009	B2
7617005	Demarais et al.	Nov 2009	B2
7620451	Demarais et al.	Nov 2009	B2
7621902	Nita et al.	Nov 2009	B2
7621929	Nita et al.	Nov 2009	B2
7626015	Feinstein et al.	Dec 2009	B2
7626235	Kinoshita	Dec 2009	B2
7632268	Edwards et al.	Dec 2009	B2
7632845	Vu et al.	Dec 2009	B2
7635383	Gumm	Dec 2009	B2
7640046	Pastore et al.	Dec 2009	B2
7641633	Laufer et al.	Jan 2010	B2
7641679	Joye et al.	Jan 2010	B2
7646544	Batchko et al.	Jan 2010	B2
7647115	Levin et al.	Jan 2010	B2
7653438	Deem et al.	Jan 2010	B2
7655006	Sauvageau et al.	Feb 2010	B2
7662114	Seip et al.	Feb 2010	B2
7664548	Amurthur et al.	Feb 2010	B2
7670279	Gertner	Mar 2010	B2
7670335	Keidar	Mar 2010	B2
7671084	Mewshaw et al.	Mar 2010	B2
7678104	Keidar	Mar 2010	B2
7678106	Lee	Mar 2010	B2
7678108	Chrisitian et al.	Mar 2010	B2
7686841	Eidenschink et al.	Mar 2010	B2
7691080	Seward et al.	Apr 2010	B2
7699809	Urmey	Apr 2010	B2
7706882	Francischelli et al.	Apr 2010	B2
7715912	Rezai et al.	May 2010	B2
7717853	Nita	May 2010	B2
7717909	Strul et al.	May 2010	B2
7717948	Demarais et al.	May 2010	B2
7722539	Carter et al.	May 2010	B2
7725157	Dumoulin et al.	May 2010	B2
7727178	Wilson et al.	Jun 2010	B2
7736317	Stephens et al.	Jun 2010	B2
7736360	Mody et al.	Jun 2010	B2
7736362	Eberl et al.	Jun 2010	B2
7738952	Yun et al.	Jun 2010	B2
7740629	Anderson et al.	Jun 2010	B2
7741299	Feinstein et al.	Jun 2010	B2
7742795	Stone et al.	Jun 2010	B2
7744594	Yamazaki et al.	Jun 2010	B2
7753907	DiMatteo et al.	Jul 2010	B2
7756583	Demarais et al.	Jul 2010	B2
7758510	Nita et al.	Jul 2010	B2
7758520	Griffin et al.	Jul 2010	B2
7759315	Cuzzocrea et al.	Jul 2010	B2
7766833	Lee et al.	Aug 2010	B2
7766878	Tremaglio, Jr. et al.	Aug 2010	B2
7766892	Keren et al.	Aug 2010	B2
7767844	Lee et al.	Aug 2010	B2
7769427	Shachar	Aug 2010	B2
7771372	Wilson	Aug 2010	B2
7771421	Stewart et al.	Aug 2010	B2
7776967	Perry et al.	Aug 2010	B2
7777486	Hargreaves et al.	Aug 2010	B2
7780660	Bourne et al.	Aug 2010	B2
7789876	Zikorus et al.	Sep 2010	B2
7792568	Zhong et al.	Sep 2010	B2
7799021	Leung et al.	Sep 2010	B2
7803168	Gifford et al.	Sep 2010	B2
7806871	Li et al.	Oct 2010	B2
7811265	Hering et al.	Oct 2010	B2
7811281	Rentrop	Oct 2010	B1
7811313	Mon et al.	Oct 2010	B2
7816511	Kawashima et al.	Oct 2010	B2
7818053	Kassab	Oct 2010	B2
7819866	Bednarek	Oct 2010	B2
7822460	Halperin et al.	Oct 2010	B2
7828837	Khoury	Nov 2010	B2
7832407	Gertner	Nov 2010	B2
7833220	Mon et al.	Nov 2010	B2
7837676	Sinelnikov et al.	Nov 2010	B2
7837720	Mon	Nov 2010	B2
7841978	Gertner	Nov 2010	B2
7846157	Kozel	Dec 2010	B2
7846160	Payne et al.	Dec 2010	B2
7846172	Makower	Dec 2010	B2
7849860	Makower et al.	Dec 2010	B2
7850685	Kunis et al.	Dec 2010	B2
7853333	Demarais	Dec 2010	B2
7854734	Biggs et al.	Dec 2010	B2
7857756	Warren et al.	Dec 2010	B2
7862565	Eder et al.	Jan 2011	B2
7863897	Slocum, Jr. et al.	Jan 2011	B2
7869854	Shachar et al.	Jan 2011	B2
7873417	Demarais et al.	Jan 2011	B2
7887538	Bleich et al.	Feb 2011	B2
7894905	Pless et al.	Feb 2011	B2
7896873	Hiller et al.	Mar 2011	B2
7901400	Wham et al.	Mar 2011	B2
7901402	Jones et al.	Mar 2011	B2
7901420	Dunn	Mar 2011	B2
7905862	Sampson	Mar 2011	B2
7918850	Govari et al.	Apr 2011	B2
7927370	Webler et al.	Apr 2011	B2
7937143	Demarais et al.	May 2011	B2
7938830	Saadat et al.	May 2011	B2
7942874	Eder et al.	May 2011	B2
7942928	Webler et al.	May 2011	B2
7946976	Gertner	May 2011	B2
7950397	Thapliyal et al.	May 2011	B2
7955293	Nita et al.	Jun 2011	B2
7956613	Wald	Jun 2011	B2
7959627	Utley et al.	Jun 2011	B2
7962854	Vance et al.	Jun 2011	B2
7967782	Laufer et al.	Jun 2011	B2
7967808	Fitzgerald et al.	Jun 2011	B2
7972327	Eberl et al.	Jul 2011	B2
7972330	Alejandro et al.	Jul 2011	B2
7983751	Zdeblick et al.	Jul 2011	B2
8001976	Gertner	Aug 2011	B2
8007440	Magnin et al.	Aug 2011	B2
8012147	Lafontaine	Sep 2011	B2
8019435	Hastings et al.	Sep 2011	B2
8021362	Deem et al.	Sep 2011	B2
8021413	Dierking et al.	Sep 2011	B2
8025661	Arnold et al.	Sep 2011	B2
8027718	Spinner et al.	Sep 2011	B2
8031927	Karl et al.	Oct 2011	B2
8033284	Porter et al.	Oct 2011	B2
8043673	Lee et al.	Oct 2011	B2
8048144	Thistle et al.	Nov 2011	B2
8052636	Moll et al.	Nov 2011	B2
8052700	Dunn	Nov 2011	B2
8062289	Babaev	Nov 2011	B2
8075580	Makower	Dec 2011	B2
8080006	Lafontaine et al.	Dec 2011	B2
8088127	Mayse et al.	Jan 2012	B2
8116883	Williams et al.	Feb 2012	B2
8119183	O'Donoghue et al.	Feb 2012	B2
8120518	Jang et al.	Feb 2012	B2
8123741	Marrouche et al.	Feb 2012	B2
8128617	Bencini et al.	Mar 2012	B2
8131371	Demarals et al.	Mar 2012	B2
8131372	Levin et al.	Mar 2012	B2
8131382	Asada	Mar 2012	B2
8137274	Weng et al.	Mar 2012	B2
8140170	Rezai et al.	Mar 2012	B2
8143316	Ueno	Mar 2012	B2
8145316	Deem et al.	Mar 2012	B2
8145317	Demarais et al.	Mar 2012	B2
8150518	Levin et al.	Apr 2012	B2
8150519	Demarais et al.	Apr 2012	B2
8150520	Demarais et al.	Apr 2012	B2
8152830	Gumm	Apr 2012	B2
8162933	Francischelli et al.	Apr 2012	B2
8168275	Lee et al.	May 2012	B2
8175711	Demarais et al.	May 2012	B2
8187261	Watson	May 2012	B2
8190238	Moll et al.	May 2012	B2
8192053	Owen et al.	Jun 2012	B2
8198611	LaFontaine et al.	Jun 2012	B2
8214056	Hoffer et al.	Jul 2012	B2
8221407	Phan et al.	Jul 2012	B2
8226637	Satake	Jul 2012	B2
8231617	Satake	Jul 2012	B2
8241217	Chiang et al.	Aug 2012	B2
8257724	Cromack et al.	Sep 2012	B2
8257725	Cromack et al.	Sep 2012	B2
8260397	Ruff et al.	Sep 2012	B2
8263104	Ho et al.	Sep 2012	B2
8273023	Razavi	Sep 2012	B2
8277379	Lau et al.	Oct 2012	B2
8287524	Siegel	Oct 2012	B2
8287532	Carroll et al.	Oct 2012	B2
8292881	Brannan et al.	Oct 2012	B2
8293703	Averback et al.	Oct 2012	B2
8295902	Salahieh et al.	Oct 2012	B2
8295912	Gertner	Oct 2012	B2
8308722	Ormsby et al.	Nov 2012	B2
8317776	Ferren et al.	Nov 2012	B2
8317810	Stangenes et al.	Nov 2012	B2
8329179	Ni et al.	Dec 2012	B2
8336705	Okahisa	Dec 2012	B2
8343031	Gertner	Jan 2013	B2
8343145	Brannan	Jan 2013	B2
8347891	Demarais et al.	Jan 2013	B2
8353945	Andreas et al.	Jan 2013	B2
8364237	Stone et al.	Jan 2013	B2
8366615	Razavi	Feb 2013	B2
8382697	Brenneman et al.	Feb 2013	B2
8388680	Starksen et al.	Mar 2013	B2
8396548	Perry et al.	Mar 2013	B2
8398629	Thistle	Mar 2013	B2
8401667	Gustus et al.	Mar 2013	B2
8403881	Ferren et al.	Mar 2013	B2
8406877	Smith et al.	Mar 2013	B2
8409172	Moll et al.	Apr 2013	B2
8409193	Young et al.	Apr 2013	B2
8409195	Young	Apr 2013	B2
8418362	Zerfas et al.	Apr 2013	B2
8452988	Wang	May 2013	B2
8454594	Demarais et al.	Jun 2013	B2
8460358	Andreas et al.	Jun 2013	B2
8465452	Kassab	Jun 2013	B2
8469919	Ingle et al.	Jun 2013	B2
8473067	Hastings et al.	Jun 2013	B2
8480663	Ingle et al.	Jul 2013	B2
8485992	Griffin et al.	Jul 2013	B2
8486060	Kotmel et al.	Jul 2013	B2
8486063	Werneth et al.	Jul 2013	B2
8488591	Miali et al.	Jul 2013	B2
20010007070	Stewart et al.	Jul 2001	A1
20010039419	Francischelli et al.	Nov 2001	A1
20020022864	Mahvi et al.	Feb 2002	A1
20020042639	Murphy-Chutorian et al.	Apr 2002	A1
20020045811	Kittrell et al.	Apr 2002	A1
20020045890	Celliers et al.	Apr 2002	A1
20020062146	Makower et al.	May 2002	A1
20020065542	Lax et al.	May 2002	A1
20020087151	Mody et al.	Jul 2002	A1
20020095197	Lardo et al.	Jul 2002	A1
20020107536	Hussein	Aug 2002	A1
20020147480	Mamayek	Oct 2002	A1
20020169444	Mest et al.	Nov 2002	A1
20020198520	Coen et al.	Dec 2002	A1
20030050635	Truckai et al.	Mar 2003	A1
20030065317	Rudie et al.	Apr 2003	A1
20030092995	Thompson	May 2003	A1
20030139689	Shturman et al.	Jul 2003	A1
20030195501	Sherman et al.	Oct 2003	A1
20030199747	Michlitsch et al.	Oct 2003	A1
20030229340	Sherry et al.	Dec 2003	A1
20030233099	Danaek et al.	Dec 2003	A1
20040010118	Zerhusen et al.	Jan 2004	A1
20040019348	Stevens et al.	Jan 2004	A1
20040019349	Fuimaono	Jan 2004	A1
20040024371	Plicchi et al.	Feb 2004	A1
20040043030	Griffiths et al.	Mar 2004	A1
20040064090	Keren et al.	Apr 2004	A1
20040073206	Foley et al.	Apr 2004	A1
20040088002	Boyle et al.	May 2004	A1
20040093055	Bartorelli et al.	May 2004	A1
20040106871	Hunyor et al.	Jun 2004	A1
20040117032	Roth	Jun 2004	A1
20040147915	Hasebe	Jul 2004	A1
20040162555	Farley et al.	Aug 2004	A1
20040167506	Chen	Aug 2004	A1
20040186356	O'Malley et al.	Sep 2004	A1
20040187875	He et al.	Sep 2004	A1
20040193211	Voegele et al.	Sep 2004	A1
20040220556	Cooper et al.	Nov 2004	A1
20040243022	Carney et al.	Dec 2004	A1
20040253304	Gross et al.	Dec 2004	A1
20040267250	Yon et al.	Dec 2004	A1
20050010095	Stewart et al.	Jan 2005	A1
20050015125	Mioduski et al.	Jan 2005	A1
20050080374	Esch et al.	Apr 2005	A1
20050096647	Steinke et al.	May 2005	A1
20050129616	Salcedo et al.	Jun 2005	A1
20050137180	Robinson et al.	Jun 2005	A1
20050143817	Hunter et al.	Jun 2005	A1
20050148842	Wang et al.	Jul 2005	A1
20050149069	Bertolero et al.	Jul 2005	A1
20050149080	Hunter et al.	Jul 2005	A1
20050149158	Hunter et al.	Jul 2005	A1
20050149173	Hunter et al.	Jul 2005	A1
20050149175	Hunter et al.	Jul 2005	A1
20050154277	Tang et al.	Jul 2005	A1
20050154445	Hunter et al.	Jul 2005	A1
20050154453	Hunter et al.	Jul 2005	A1
20050154454	Hunter et al.	Jul 2005	A1
20050165389	Swain et al.	Jul 2005	A1
20050165391	Maguire et al.	Jul 2005	A1
20050165467	Hunter et al.	Jul 2005	A1
20050165488	Hunter et al.	Jul 2005	A1
20050175661	Hunter et al.	Aug 2005	A1
20050175662	Hunter et al.	Aug 2005	A1
20050175663	Hunter et al.	Aug 2005	A1
20050177103	Hunter et al.	Aug 2005	A1
20050177225	Hunter et al.	Aug 2005	A1
20050181004	Hunter et al.	Aug 2005	A1
20050181008	Hunter et al.	Aug 2005	A1
20050181011	Hunter et al.	Aug 2005	A1
20050181977	Hunter et al.	Aug 2005	A1
20050182479	Bonsignore et al.	Aug 2005	A1
20050183728	Hunter et al.	Aug 2005	A1
20050186242	Hunter et al.	Aug 2005	A1
20050186243	Hunter et al.	Aug 2005	A1
20050191331	Hunter et al.	Sep 2005	A1
20050203410	Jenkins	Sep 2005	A1
20050209587	Joye et al.	Sep 2005	A1
20050214205	Salcedo et al.	Sep 2005	A1
20050214207	Salcedo et al.	Sep 2005	A1
20050214208	Salcedo et al.	Sep 2005	A1
20050214209	Salcedo et al.	Sep 2005	A1
20050214210	Salcedo et al.	Sep 2005	A1
20050214268	Cavanagh et al.	Sep 2005	A1
20050228286	Messerly et al.	Oct 2005	A1
20050228415	Gertner	Oct 2005	A1
20050228460	Levin et al.	Oct 2005	A1
20050232921	Rosen et al.	Oct 2005	A1
20050234312	Suzuki et al.	Oct 2005	A1
20050245862	Seward	Nov 2005	A1
20050251116	Steinke et al.	Nov 2005	A1
20050252553	Ginggen	Nov 2005	A1
20050256398	Hastings et al.	Nov 2005	A1
20050267556	Shuros et al.	Dec 2005	A1
20050273149	Tran et al.	Dec 2005	A1
20060004323	Chang et al.	Jan 2006	A1
20060018949	Ammon et al.	Jan 2006	A1
20060024564	Manclaw	Feb 2006	A1
20060025765	Landman et al.	Feb 2006	A1
20060062786	Salcedo et al.	Mar 2006	A1
20060083194	Dhrimaj et al.	Apr 2006	A1
20060085054	Zikorus et al.	Apr 2006	A1
20060089637	Werneth et al.	Apr 2006	A1
20060089638	Carmel et al.	Apr 2006	A1
20060095096	DeBenedictis et al.	May 2006	A1
20060106375	Werneth et al.	May 2006	A1
20060142790	Gertner	Jun 2006	A1
20060147492	Hunter et al.	Jul 2006	A1
20060167106	Zhang et al.	Jul 2006	A1
20060167498	DiLorenzo	Jul 2006	A1
20060171895	Bucay-Couto	Aug 2006	A1
20060182873	Klisch et al.	Aug 2006	A1
20060184221	Stewart et al.	Aug 2006	A1
20060195139	Gertner	Aug 2006	A1
20060206150	Demarais et al.	Sep 2006	A1
20060224153	Fischell et al.	Oct 2006	A1
20060239921	Mangat et al.	Oct 2006	A1
20060240070	Cromack et al.	Oct 2006	A1
20060247266	Yamada et al.	Nov 2006	A1
20060247760	Ganesan et al.	Nov 2006	A1
20060263393	Demopulos et al.	Nov 2006	A1
20060269555	Salcedo et al.	Nov 2006	A1
20060271111	Demarais et al.	Nov 2006	A1
20060287644	Inganas et al.	Dec 2006	A1
20070016184	Cropper et al.	Jan 2007	A1
20070016274	Boveja et al.	Jan 2007	A1
20070027390	Maschke et al.	Feb 2007	A1
20070043077	Mewshaw et al.	Feb 2007	A1
20070043409	Brian et al.	Feb 2007	A1
20070049924	Rahn	Mar 2007	A1
20070066972	Ormsby et al.	Mar 2007	A1
20070067883	Sretavan	Mar 2007	A1
20070073151	Lee	Mar 2007	A1
20070093710	Maschke	Apr 2007	A1
20070100405	Thompson et al.	May 2007	A1
20070106247	Burnett et al.	May 2007	A1
20070112327	Yun et al.	May 2007	A1
20070118107	Francischelli et al.	May 2007	A1
20070129720	Demarais et al.	Jun 2007	A1
20070129760	Demarais et al.	Jun 2007	A1
20070129761	Demarais et al.	Jun 2007	A1
20070135875	Demarais et al.	Jun 2007	A1
20070149963	Matsukuma et al.	Jun 2007	A1
20070162109	Davila et al.	Jul 2007	A1
20070173805	Weinberg et al.	Jul 2007	A1
20070179496	Swoyer et al.	Aug 2007	A1
20070203480	Mody et al.	Aug 2007	A1
20070207186	Scanlon et al.	Sep 2007	A1
20070208134	Hunter et al.	Sep 2007	A1
20070208210	Gelfand et al.	Sep 2007	A1
20070208256	Marilla	Sep 2007	A1
20070208301	Evard et al.	Sep 2007	A1
20070219576	Cangialosi	Sep 2007	A1
20070225781	Saadat et al.	Sep 2007	A1
20070233170	Gertner	Oct 2007	A1
20070239062	Chopra et al.	Oct 2007	A1
20070248639	Demopulos et al.	Oct 2007	A1
20070249703	Mewshaw et al.	Oct 2007	A1
20070254833	Hunter et al.	Nov 2007	A1
20070265687	Deem et al.	Nov 2007	A1
20070278103	Hoerr et al.	Dec 2007	A1
20070282302	Wachsman et al.	Dec 2007	A1
20070292411	Salcedo et al.	Dec 2007	A1
20070293782	Marino	Dec 2007	A1
20070299043	Hunter et al.	Dec 2007	A1
20080004673	Rossing et al.	Jan 2008	A1
20080009927	Vilims	Jan 2008	A1
20080015501	Gertner	Jan 2008	A1
20080021408	Jacobsen et al.	Jan 2008	A1
20080033049	Mewshaw	Feb 2008	A1
20080039746	Hissong et al.	Feb 2008	A1
20080039830	Munger et al.	Feb 2008	A1
20080051454	Wang	Feb 2008	A1
20080064957	Spence	Mar 2008	A1
20080071269	Hilario et al.	Mar 2008	A1
20080071306	Gertner	Mar 2008	A1
20080082109	Moll et al.	Apr 2008	A1
20080086072	Bonutti et al.	Apr 2008	A1
20080091193	Kauphusman et al.	Apr 2008	A1
20080097251	Babaev	Apr 2008	A1
20080097426	Root et al.	Apr 2008	A1
20080108867	Zhou	May 2008	A1
20080119879	Brenneman et al.	May 2008	A1
20080125772	Stone et al.	May 2008	A1
20080132450	Lee et al.	Jun 2008	A1
20080140002	Ramzipoor et al.	Jun 2008	A1
20080147002	Gertner	Jun 2008	A1
20080161662	Golijanin et al.	Jul 2008	A1
20080161717	Gertner	Jul 2008	A1
20080161801	Steinke et al.	Jul 2008	A1
20080171974	Lafontaine et al.	Jul 2008	A1
20080172035	Starksen et al.	Jul 2008	A1
20080172104	Kieval et al.	Jul 2008	A1
20080188912	Stone et al.	Aug 2008	A1
20080188913	Stone et al.	Aug 2008	A1
20080208162	Joshi	Aug 2008	A1
20080208169	Boyle et al.	Aug 2008	A1
20080213331	Gelfand et al.	Sep 2008	A1
20080215117	Gross	Sep 2008	A1
20080221448	Khuri-Yakub et al.	Sep 2008	A1
20080234790	Bayer et al.	Sep 2008	A1
20080243091	Humphreys et al.	Oct 2008	A1
20080245371	Gruber	Oct 2008	A1
20080249525	Lee et al.	Oct 2008	A1
20080249547	Dunn	Oct 2008	A1
20080255550	Bell	Oct 2008	A1
20080255642	Zarins et al.	Oct 2008	A1
20080262489	Steinke	Oct 2008	A1
20080275484	Gertner	Nov 2008	A1
20080281312	Werneth et al.	Nov 2008	A1
20080281347	Gertner	Nov 2008	A1
20080287918	Rosenman et al.	Nov 2008	A1
20080294037	Richter	Nov 2008	A1
20080300618	Gertner	Dec 2008	A1
20080312644	Fourkas et al.	Dec 2008	A1
20080312673	Viswanathan et al.	Dec 2008	A1
20080317818	Griffith et al.	Dec 2008	A1
20090018486	Goren et al.	Jan 2009	A1
20090018609	DiLorenzo	Jan 2009	A1
20090024194	Arcot-Krishnamurthy et al.	Jan 2009	A1
20090030312	Hadjicostis	Jan 2009	A1
20090036948	Levin et al.	Feb 2009	A1
20090043372	Northrop et al.	Feb 2009	A1
20090054082	Kim et al.	Feb 2009	A1
20090062873	Wu et al.	Mar 2009	A1
20090069671	Anderson	Mar 2009	A1
20090076409	Wu et al.	Mar 2009	A1
20090088735	Abboud et al.	Apr 2009	A1
20090105631	Kieval	Apr 2009	A1
20090112202	Young	Apr 2009	A1
20090118620	Tgavalekos et al.	May 2009	A1
20090118726	Auth et al.	May 2009	A1
20090125099	Weber et al.	May 2009	A1
20090131798	Minar et al.	May 2009	A1
20090143640	Saadat et al.	Jun 2009	A1
20090156988	Ferren et al.	Jun 2009	A1
20090157057	Ferren et al.	Jun 2009	A1
20090157161	Desai et al.	Jun 2009	A1
20090171333	Hon	Jul 2009	A1
20090192558	Whitehurst et al.	Jul 2009	A1
20090198223	Thilwind et al.	Aug 2009	A1
20090203962	Miller et al.	Aug 2009	A1
20090203993	Mangat et al.	Aug 2009	A1
20090204170	Hastings et al.	Aug 2009	A1
20090210953	Moyer et al.	Aug 2009	A1
20090216317	Cromack et al.	Aug 2009	A1
20090221955	Babaev	Sep 2009	A1
20090226429	Salcedo et al.	Sep 2009	A1
20090240249	Chan et al.	Sep 2009	A1
20090247933	Maor et al.	Oct 2009	A1
20090247966	Gunn et al.	Oct 2009	A1
20090248012	Maor et al.	Oct 2009	A1
20090253974	Rahme	Oct 2009	A1
20090264755	Chen et al.	Oct 2009	A1
20090270850	Zhou et al.	Oct 2009	A1
20090281533	Ingle et al.	Nov 2009	A1
20090287137	Crowley	Nov 2009	A1
20090318749	Stolen et al.	Dec 2009	A1
20100009267	Chase et al.	Jan 2010	A1
20100030061	Canfield et al.	Feb 2010	A1
20100048983	Ball et al.	Feb 2010	A1
20100049099	Thapliyal et al.	Feb 2010	A1
20100049186	Ingle et al.	Feb 2010	A1
20100049188	Nelson et al.	Feb 2010	A1
20100049191	Habib et al.	Feb 2010	A1
20100049283	Johnson	Feb 2010	A1
20100069837	Rassat et al.	Mar 2010	A1
20100076299	Gustus et al.	Mar 2010	A1
20100076425	Carroux	Mar 2010	A1
20100087782	Ghaffari et al.	Apr 2010	A1
20100106005	Karczmar et al.	Apr 2010	A1
20100114244	Manda et al.	May 2010	A1
20100130836	Malchano et al.	May 2010	A1
20100137860	Demarais et al.	Jun 2010	A1
20100137952	Demarais et al.	Jun 2010	A1
20100160903	Krespi	Jun 2010	A1
20100160906	Jarrard	Jun 2010	A1
20100168624	Sliwa	Jul 2010	A1
20100168731	Wu et al.	Jul 2010	A1
20100168739	Wu et al.	Jul 2010	A1
20100174282	Demarais et al.	Jul 2010	A1
20100191112	Demarais et al.	Jul 2010	A1
20100191232	Boveda	Jul 2010	A1
20100217162	Hissong et al.	Aug 2010	A1
20100222786	Kassab	Sep 2010	A1
20100222851	Deem et al.	Sep 2010	A1
20100222854	Demarais et al.	Sep 2010	A1
20100228122	Keenan et al.	Sep 2010	A1
20100249604	Hastings et al.	Sep 2010	A1
20100249773	Clark et al.	Sep 2010	A1
20100256616	Katoh et al.	Oct 2010	A1
20100256623	Nicolas	Oct 2010	A1
20100268217	Habib	Oct 2010	A1
20100268307	Demarais et al.	Oct 2010	A1
20100284927	Lu et al.	Nov 2010	A1
20100286684	Hata et al.	Nov 2010	A1
20100298821	Garbagnati	Nov 2010	A1
20100305036	Barnes et al.	Dec 2010	A1
20100312141	Keast et al.	Dec 2010	A1
20100324472	Wulfman	Dec 2010	A1
20110009750	Taylor et al.	Jan 2011	A1
20110021976	Li et al.	Jan 2011	A1
20110034832	Cioanta et al.	Feb 2011	A1
20110040324	McCarthy et al.	Feb 2011	A1
20110044942	Puri et al.	Feb 2011	A1
20110060324	Wu et al.	Mar 2011	A1
20110071400	Hastings et al.	Mar 2011	A1
20110071401	Hastings et al.	Mar 2011	A1
20110077498	McDaniel	Mar 2011	A1
20110092781	Gertner	Apr 2011	A1
20110092880	Gertner	Apr 2011	A1
20110104061	Seward	May 2011	A1
20110112400	Emery et al.	May 2011	A1
20110118600	Gertner	May 2011	A1
20110118726	De La Rama et al.	May 2011	A1
20110130708	Perry et al.	Jun 2011	A1
20110137155	Weber et al.	Jun 2011	A1
20110144479	Hastings et al.	Jun 2011	A1
20110146673	Keast et al.	Jun 2011	A1
20110166499	Demarais et al.	Jul 2011	A1
20110178570	Demarais	Jul 2011	A1
20110200171	Beetel et al.	Aug 2011	A1
20110202098	Demarais et al.	Aug 2011	A1
20110207758	Sobotka et al.	Aug 2011	A1
20110208096	Demarais et al.	Aug 2011	A1
20110257523	Hastings et al.	Oct 2011	A1
20110257564	Demarais et al.	Oct 2011	A1
20110257622	Salahieh et al.	Oct 2011	A1
20110257641	Hastings et al.	Oct 2011	A1
20110257642	Griggs, III	Oct 2011	A1
20110263921	Vrba et al.	Oct 2011	A1
20110264011	Wu et al.	Oct 2011	A1
20110264075	Leung et al.	Oct 2011	A1
20110264086	Ingle	Oct 2011	A1
20110264116	Kocur et al.	Oct 2011	A1
20110270238	Rizq et al.	Nov 2011	A1
20110306851	Wang	Dec 2011	A1
20110319809	Smith	Dec 2011	A1
20120029496	Smith	Feb 2012	A1
20120029500	Jenson	Feb 2012	A1
20120029505	Jenson	Feb 2012	A1
20120029509	Smith	Feb 2012	A1
20120029510	Haverkost	Feb 2012	A1
20120029511	Smith et al.	Feb 2012	A1
20120029512	Willard et al.	Feb 2012	A1
20120029513	Smith et al.	Feb 2012	A1
20120059241	Hastings et al.	Mar 2012	A1
20120059286	Hastings et al.	Mar 2012	A1
20120065506	Smith	Mar 2012	A1
20120065554	Pikus	Mar 2012	A1
20120095461	Herscher et al.	Apr 2012	A1
20120101413	Beetel et al.	Apr 2012	A1
20120101490	Smith	Apr 2012	A1
20120101538	Ballakur et al.	Apr 2012	A1
20120109021	Hastings et al.	May 2012	A1
20120116382	Ku et al.	May 2012	A1
20120116383	Mauch et al.	May 2012	A1
20120116392	Willard	May 2012	A1
20120116438	Salahieh et al.	May 2012	A1
20120116486	Naga et al.	May 2012	A1
20120123243	Hastings	May 2012	A1
20120123258	Willard	May 2012	A1
20120123261	Jenson et al.	May 2012	A1
20120123303	Sogard et al.	May 2012	A1
20120123406	Edmunds et al.	May 2012	A1
20120130289	Demarais et al.	May 2012	A1
20120130345	Levin et al.	May 2012	A1
20120130359	Turovskiy	May 2012	A1
20120130360	Buckley et al.	May 2012	A1
20120130362	Hastings et al.	May 2012	A1
20120130368	Jenson	May 2012	A1
20120130458	Ryba et al.	May 2012	A1
20120136344	Buckley et al.	May 2012	A1
20120136349	Hastings	May 2012	A1
20120136350	Goshgarian et al.	May 2012	A1
20120136417	Buckley et al.	May 2012	A1
20120136418	Buckley et al.	May 2012	A1
20120143181	Demarais et al.	Jun 2012	A1
20120143293	Mauch et al.	Jun 2012	A1
20120143294	Clark et al.	Jun 2012	A1
20120150267	Buckley et al.	Jun 2012	A1
20120157986	Stone et al.	Jun 2012	A1
20120157987	Steinke et al.	Jun 2012	A1
20120157988	Stone et al.	Jun 2012	A1
20120157989	Stone et al.	Jun 2012	A1
20120157992	Smith et al.	Jun 2012	A1
20120157993	Jenson	Jun 2012	A1
20120158101	Stone et al.	Jun 2012	A1
20120158104	Huynh et al.	Jun 2012	A1
20120172837	Demarais et al.	Jul 2012	A1
20120172870	Jenson et al.	Jul 2012	A1
20120184952	Jenson et al.	Jul 2012	A1
20120197198	Demarais et al.	Aug 2012	A1
20120197252	Deem et al.	Aug 2012	A1
20120232409	Stahmann et al.	Sep 2012	A1
20120265066	Crow et al.	Oct 2012	A1
20120265198	Crow et al.	Oct 2012	A1
20130012844	Demarais et al.	Jan 2013	A1
20130012866	Deem et al.	Jan 2013	A1
20130012867	Demarais et al.	Jan 2013	A1
20130013024	Levin et al.	Jan 2013	A1
20130023865	Steinke et al.	Jan 2013	A1
20130035681	Subramanaim et al.	Feb 2013	A1
20130066316	Steinke et al.	Mar 2013	A1
20130085489	Fain et al.	Apr 2013	A1
20130090563	Weber	Apr 2013	A1
20130090578	Smith et al.	Apr 2013	A1
20130090647	Smith	Apr 2013	A1
20130090649	Smith et al.	Apr 2013	A1
20130090650	Jenson et al.	Apr 2013	A1
20130090651	Smith	Apr 2013	A1
20130090652	Jenson	Apr 2013	A1
20130096550	Hill	Apr 2013	A1
20130096553	Hill et al.	Apr 2013	A1
20130096554	Groff et al.	Apr 2013	A1
20130096604	Hanson et al.	Apr 2013	A1
20130110106	Richardson	May 2013	A1
20130116687	Willard	May 2013	A1
20130165764	Scheuermann et al.	Jun 2013	A1
20130165844	Shuros et al.	Jun 2013	A1
20130165916	Mathur et al.	Jun 2013	A1
20130165917	Mathur et al.	Jun 2013	A1
20130165920	Weber et al.	Jun 2013	A1
20130165923	Mathur et al.	Jun 2013	A1
20130165924	Mathur et al.	Jun 2013	A1
20130165925	Mathur et al.	Jun 2013	A1
20130165926	Mathur et al.	Jun 2013	A1
20130165990	Mathur et al.	Jun 2013	A1
20130172815	Perry et al.	Jul 2013	A1
20130172872	Subramaniam et al.	Jul 2013	A1
20130172877	Subramaniam et al.	Jul 2013	A1
20130172878	Smith	Jul 2013	A1
20130172879	Sutermeister	Jul 2013	A1
20130172880	Willard	Jul 2013	A1
20130172881	Hill et al.	Jul 2013	A1
20140074083	Horn et al.	Mar 2014	A1
20140163372	Deladi	Jun 2014	A1

Foreign Referenced Citations (44)

Number	Date	Country
10038737	Feb 2002	DE
1053720	Nov 2000	EP
1180004	Feb 2002	EP
1335677	Aug 2003	EP
1874211	Jan 2008	EP
1906853	Apr 2008	EP
1961394	Aug 2008	EP
1620156	Jul 2009	EP
2076193	Jul 2009	EP
2091455	Aug 2009	EP
2197533	Jun 2010	EP
2208506	Jul 2010	EP
1579889	Aug 2010	EP
2092957	Jan 2011	EP
2349044	Aug 2011	EP
2027882	Oct 2011	EP
2378956	Oct 2011	EP
2037840	Dec 2011	EP
2204134	Apr 2012	EP
2320821	Oct 2012	EP
2456301	Jul 2009	GB
9858588	Dec 1998	WO
9900060	Jan 1999	WO
9935986	Jul 1999	WO
0047118	Aug 2000	WO
0066021	Nov 2000	WO
0195820	Dec 2001	WO
03026525	Apr 2003	WO
2004100813	Nov 2004	WO
2004110258	Dec 2004	WO
2005041810	May 2005	WO
2006105121	Oct 2006	WO
2008014465	Jan 2008	WO
2009121017	Oct 2009	WO
2010067360	Jun 2010	WO
2010102310	Sep 2010	WO
2010132703	Nov 2010	WO
2011005901	Jan 2011	WO
2011053757	May 2011	WO
2011053772	May 2011	WO
2011091069	Jul 2011	WO
2011130534	Oct 2011	WO
2012019156	Feb 2012	WO
2013049601	Apr 2013	WO

Non-Patent Literature Citations (68)

Entry
US 8,398,630, 03/2013, Demarais et al. (withdrawn)
CardioVascular Technologies Inc., “Heated Balloon Device Technology,” 11 pages, 2008.
Strategic Business Development, Inc., “Thermal and Disruptive Angioplasty: A Physician's Guide,” 8 pages, 1990.
Zhang et al., “Non-contact Radio-Frequency Ablation for Obtaining Deeper Lesions,” IEEE Transaction on Biomedical Engineering, vol. 50(2): 218-223, Feb. 2003.
Lazebnik et al., “Tissue Strain Analytics Virtual Touch Tissue Imaging and Qualification,” Siemens Whitepaper, 7 pages, Oct. 2008.
Han et al., “Third-Generation Cryosurgery for Primary and Recurrent Prostate Caner,” BJU International, vol. 93: 14-18, 2004.
Zhou et al., “Mechanism Research of Cryoanalgesia,” Neurological Research, Forefront Publishing Group, 17: 307-311, Aug. 1995.
Florete, “Cryoblative Procedure for Back Pain,” Jacksonville Medicine, Oct. 1998, 10 pages, printed Dec. 2009.
Stevenson, “Irrigated RF Ablation: Power Titration and Fluid Management for Optimal Safety Efficacy,” 4 pages, 2005.
Giliatt et al., “The Cause of Nerve Damage in Acute Compression,” Trans Am Neurol Assoc, 99: 71-4, 1974.
Omura et al., “A Mild Acute Compression Induces Neurapraxia in Rat Sciatic Nerve,” The International Journal of Neuroscience, vol. 114 (12):1561-1572, Dec. 2004.
Baun, “Interaction with Soft Tissue,” Principles of General & Vascular Sonography, Chapter 2, pp. 23-24, Before Mar. 2012.
Blue Cross Blue Shield Medical Policy, “Surgery Section—MRI-Guided Focused Ultrasound (MRgFUS) for the Treatment of Uterine Fibroids and Other Tumors,” 5 pages, printed Oct. 19, 2009.
Gentry et al., “Combines 3D Intracardiac Echo and Ultrasound Ablation,” Medical Imaging 2003: Ultrasonic and Signal Processing, 5035: 166-173, 2003.
Lafon et al., “Optmizing the Shape of Ultrasound Transducers for Interstitial Thermal Ablations,” MEd Phys. Mar. 2002; 29(3): 290-7 (abstract only), Mar. 2002.
G. Ter Haar, “Ultrasound Focal Beam Surgery,” Ultrasound in Med. & Biol., 1995, 21(9): 1089-1100.
Seip et al., “Transurethral High Intensity Focused Ultrasound: Catheter Based Prototypes and Experimental Results,” IEEE Ultrasonics Symposium Proceeding, 2000, 4 pages.
Toytman et al., “Tissue Dissection with Ultrafast Laser Using Extended and Multiple Foci,” SPIE Proceeding, Optical Interactions with Tissues and Cells XXI, 7562: 1-10, 2010.
Zhou et al., “Non-Thermal Ablation of Rabbit Liver VX2 Tumore by Pulsed High Intensity Focused Ultrasound Contrast Agent: Pathological Characteristics,” World Journal of Gastroenterology, 14(43): 6743-6747, Nov. 21, 2008.
Van Den Berg, “Light echoes image the human body,” OLE, p. 35-37, Oct. 2001.
“IntraLuminal: Products,” IntraLuminal Therapeutics, Inc., p. 1-9, 2003.
“Laser Catheter to Aid Coronary Surgery,” TechTalk: MIT, p. 1-4, Jan. 9, 1991.
“Optical Coherence Tomography: LightLab Imaging Starts US Cardiology Clinical Investigations,” LightLab Imaging Technology Company Press Release, Jun. 25, 2002, <http://www.lightlabimaging.com/press/cardtrails.html> 2 pages.
“Optical Coherence Tomography: LightLab Sees Bright Prospects for Cardiac Application of OCT Technology,” LightLab Imaging Technology, The Gray Sheet, Medical Devices, Diagnostics, & Instrumentation, 27(35), Aug. 27, 2001, <http://www.lightlabimaging.com/press/graysheet.html> 1 page.
“Products—Functional Measurement,” Volcano Functional Measurement Products US, p. 1-2, Mar. 24, 2003.
Brown et al., “Radiofrequency capacitive heaters: the effect of coupling medium resistivity on power absorption along a mouse leg,” Physics in Medicine and Biology, 38: 1-12, 1993.
Carrington, “Future of CVI: It's all about plaque: Identification of vulnerable lesions, not ‘rusty pipes,’ could become cornerstone of preventive cardiology,” Diagnostic Imaging Special Edition Forum, 5 pages total, retrieved on Sep. 3, 2003.
Chen et al., “Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo,” EuroIntervention, p. 1-8, 2013.
Cimino, “Preventing plaque attack,” Mass High Tech, 3 pages total, retrieved on Sep. 3, 2003 <http://Masshightech.com/displayarticledetail.ap?art—id=52283&cat—id=10>, 2001.
Dahm et al., “Relation of Degree of Laser Debulking of In-Stent Restenosis as a Predictor of Restenosis Rate,” The American Journal of Cardiology, 90:68-70, 2002.
De Korte et al., “Characterization of Plaque Components With Intravascular Ultrasound Elastography in Human Femoral and Coronary Arteries In Vitro,” Circulation, Aug. 8, 2000, p. 617-623.
Durney et al., “Radiofrequency Radiation Dosimetry Handbook,” 7 pages, Fourth Edition, Oct. 1986.
Pieper et al. “Design and implementation of a new computerized system for intraoperative cardiac mapping”, J. Appl. Physiol. 71(4): 1529-1539, 1991.
Fournier-Desseux et al., “Assessment of 1-lead and 2-lead electrode patterns in electrical impedance endotomography,” Physiological Measurement, Institute of Physics Publishing, 26:337-349, 2005.
Fram et al., “Feasibility of Radiofrequency Powered, Thermal Balloon Ablation of Atrioventricular Bypass Tracts Via the Coronary Sinus: In Vivo Canine Studies,” Pace, 18:1518-1530, Aug. 1995.
Fram et al., “Low Pressure Radiofrequency Balloon Angioplasty: Evaluation in Porcine Peripheral Arteries,” JACC, American College of Cardiology, 21(6):1512-1521, 1993.
Fujimori et al., “Significant Prevention of In-Stent Restenosis by Evans Blue in Patients with Acute Myocardial Infarction,” American Heart Association, 2002.
Fujita et al., “Sarpogrelate, An Antagonist of 5-HT(2A) Receptor, Treatment Reduces Restenosis After Coronary Stenting,” American Heart Association, 2002.
Gabriel, “Appendix A: Experimental Data,” p. 1-21, 1999.
Gabriel, “Appendix C: Modeling the frequency dependence of the dielectric properties to a 4 dispersions spectrum,” p. 1-49, Nov. 6, 1997.
Gregory et al., “Liquid Core Light Guide for Laser Angioplasty,” The Journal of Quantum Electronics, 26 (12):2289-2296, Dec. 1990.
Kaplan et al., “Healing after Arterial Dilatation with Radiofrequency Thermal and Nonthermal Balloon Angioplasty Sytems,” Journal of Investigative Surgery, 6:33-52, 1993.
Kolata, “New Studies Question Value of Opening Arteries,” The New York Times [online], 5 pages total, <http://nytimes.com/2004/03/21/health/21HEAR.html?ei=5070&en=641bc03214e&ex=11067>, Mar. 21, 2004.
Konings et al., “Development of an Intravascular Impedance Catheter for Detection of Fatty Lesions in Arteries,” IEEE Transactions on Medical Imaging, 16(4):439-444, Aug. 1997.
Kurtz et al., “Lamellar Refractive Surgery with Scanned Intrastromal Picosecond and Femtosecond Laser Pulses in Animal Eyes,” Journal of Refractive Surgery, 14:541-548, Sep./Oct. 1998.
Lee et al., “Thermal Compression and Molding of Atherosclerotic Vascular Tissue With Use of Radiofrequency Energy: Implications for Radiofrequency Balloon Angioplasty,” JACC, American College of Cardiology, 13(5):1167-1175, 1989.
Lima et al., “Efficacy and Safety of Oral Sirolimus to Treat and Prevent In-Stent Restenosis: A Pilot Study Results,” American Heart Association, p. 2929, 2002.
Lima et al., “Systemic Immunosuppression Inhibits In-Stent Coronary Intimal Proliferation in Renal Transplant Patients,” American Heart Association, p. 2928, 2002.
Morice et al., “A Randomized Comparison of a Sirolimus-Eluting Stent With a Standard Stent for Coronary Revascularization,” The New England Journal of Medicine, 346(23):1773-1780, Jun. 6, 2002.
Muller-Leisse et al., “Effectiveness and Safety of Ultrasonic Atherosclerotic Plaque Ablation: In Vitro Investigation,” CardioVascular and Interventional Radiology, 16:303-307, 1993.
Nair et al., “Regularized Autoregressive Analysis of Intravascular Ultrasound Backscatter: Improvement in Spatial Accuracy of Tissue Maps,” IEEE Transactions on Ultrasonics, 51(4):420-431, Apr. 2004.
Popma et al., “Percutaneous Coronary and Valvular Intervention,” Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th edition, p. 1364-1405, 2005.
Resar et al., “Endoluminal Sealing of Vascular Wall Disruptions With Radiofrequency-Heated Balloon Angioplasty,” Catheterization and Cardiovascular Diagnosis, 29:161-167, 1993.
Romer et al., “Histopathology of Human Coronary Atherosclerosis by Quantifying Its Chemical Composition With Raman Spectroscopy,” Circulation, 97:878-885, 1998.
Schauerte et al., “Catheter Ablation of Cardiac Autonomic Nerves for Prevention of Vagal Atrial Fibrillation,” Circulation, 102:2774-2780, 2000.
Scheller et al., “Intracoronary Paclitaxel Added to Contrast Media Inhibits In-Stent Restenosis of Porcine Coronary Arteries,” American Heart Association, p. 2227, 2002.
Scheller et al., “Potential solutions to the current problem: coated balloon,” Eurolntervention, 4(Supplement C): C63-C66, 2008.
Shaffer, “Scientific basis of laser energy,” Clinics in Sports Medicine, 21:585-598, 2002.
Shmatukha et al., “MRI temperature mapping during thermal balloon angioplasty,” Physics in Medicine and Biology, 51:N163-N171, 2006.
Slager et al., “Vaporization of Atherosclerotic Plaques by Spark Erosion,” J Am Coll Cardiol, p. 21-25, 1985.
Stiles et al., “Simulated Characterization of Atherosclerotic Lesions in the Coronary Arteries by Measurement of Bioimpedance,” IEEE Transactions on Biomedical Engineering, 50(7): 916-921, Jul. 2003.
Suselbeck et al., “In vivo intravascular electric impedance spectroscopy using a new catheter with integrated microelectrodes,” Basic Res Cardiol, 100:28-34, 2005.
Suselbeck et al., “Intravascular electric impedance spectroscopy of atherosclerotic lesions using a new impedance catheter system,” Basic Res Cardiol, 100:446-452, 2005.
Tepe et al., “Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the Leg,” The New England Journal of Medicine, 358:689-699, 2008.
“Optical Coherence Tomography: Advantages of OCT,” LightLab Imaging Technology, printed Sep. 3, 2003.
“Optical Coherence Tomography: Image Gallery Cardiovascular Procedures,” LightLab Imaging Technology, printed Sep. 3, 2003.
“Optical Coherence Tomography: What is OCT?,” LightLab Imaging Technology, printed Sep. 3, 2003.
“Optical Coherence Tomography: Why Use OCT?,” LightLab Imaging Technology, printed Sep. 3, 2003.

Related Publications (1)

	Number	Date	Country
	20150105715 A1	Apr 2015	US

Provisional Applications (1)

	Number	Date	Country
	61891241	Oct 2013	US

Ultrasound ablation catheter with cooling infusion and centering basket

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

CPC

Field of Search

CPC

International Classifications

Term Extension

Abstract